<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.8.27">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>TIGIT – Clinical Trial Watch</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="https://cdn.jsdelivr.net/npm/jquery@3.5.1/dist/jquery.min.js" integrity="sha384-ZvpUoO/+PpLXR1lu4jmpXWu80pZlYUAfxl5NsBMWOEPSjUn/6Z/hRTt8+pR6L4N2" crossorigin="anonymous"></script><script src="../site_libs/quarto-nav/quarto-nav.js"></script>
<script src="../site_libs/quarto-nav/headroom.min.js"></script>
<script src="../site_libs/clipboard/clipboard.min.js"></script>
<script src="../site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="../site_libs/quarto-search/fuse.min.js"></script>
<script src="../site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="../">
<script src="../site_libs/quarto-html/quarto.js" type="module"></script>
<script src="../site_libs/quarto-html/tabsets/tabsets.js" type="module"></script>
<script src="../site_libs/quarto-html/axe/axe-check.js" type="module"></script>
<script src="../site_libs/quarto-html/popper.min.js"></script>
<script src="../site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="../site_libs/quarto-html/anchor.min.js"></script>
<link href="../site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="../site_libs/quarto-html/quarto-syntax-highlighting-ed96de9b727972fe78a7b5d16c58bf87.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="../site_libs/bootstrap/bootstrap.min.js"></script>
<link href="../site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="../site_libs/bootstrap/bootstrap-0b1189524dc19e09ab363e9b4d3e2f65.min.css" rel="stylesheet" append-hash="true" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 50,
  "keyboard-shortcut": [
    "f",
    "/",
    "s"
  ],
  "show-item-context": false,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-text-placeholder": "",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>
<script src="https://cdn.jsdelivr.net/npm/requirejs@2.3.6/require.min.js" integrity="sha384-c9c+LnTbwQ3aujuU7ULEPVvgLs+Fn6fJUvIGTsuu1ZcCf11fiEubah0ttpca4ntM sha384-6V1/AdqZRWk1KAlWbKBlGhN7VG4iE/yAZcO6NZPMF8od0vukrvr0tg4qY6NSrItx" crossorigin="anonymous"></script>

<script type="application/javascript">define('jquery', [],function() {return window.jQuery;})</script>
<script type="text/javascript">
window.PlotlyConfig = {MathJaxConfig: 'local'};
if (window.MathJax && window.MathJax.Hub && window.MathJax.Hub.Config) {window.MathJax.Hub.Config({SVG: {font: "STIX-Web"}});}
</script>
<script type="module">import "https://cdn.plot.ly/plotly-3.3.1.min"</script>



<link rel="stylesheet" href="../styles.css">
</head>

<body class="nav-fixed quarto-light">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg " data-bs-theme="dark">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container mx-auto">
    <a class="navbar-brand" href="../index.html">
    <span class="navbar-title">Clinical Trial Watch</span>
    </a>
  </div>
            <div id="quarto-search" class="" title="Search"></div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" role="menu" aria-expanded="false" aria-label="Toggle navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll me-auto">
  <li class="nav-item">
    <a class="nav-link" href="../index.html"> 
<span class="menu-text">Home</span></a>
  </li>  
  <li class="nav-item dropdown ">
    <a class="nav-link dropdown-toggle" href="#" id="nav-menu-targets" role="link" data-bs-toggle="dropdown" aria-expanded="false">
 <span class="menu-text">Targets</span>
    </a>
    <ul class="dropdown-menu" aria-labelledby="nav-menu-targets">    
        <li>
    <a class="dropdown-item" href="../targets/ccr8.html">
 <span class="dropdown-text">CCR8</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../targets/tigit.html">
 <span class="dropdown-text">TIGIT</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../targets/ige.html">
 <span class="dropdown-text">IgE</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../targets/b7-h3.html">
 <span class="dropdown-text">B7-H3</span></a>
  </li>  
    </ul>
  </li>
  <li class="nav-item">
    <a class="nav-link" href="../about.html"> 
<span class="menu-text">About</span></a>
  </li>  
</ul>
          </div> <!-- /navcollapse -->
            <div class="quarto-navbar-tools">
</div>
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">On this page</h2>
   
  <ul>
  <li><a href="#visual-summary" id="toc-visual-summary" class="nav-link active" data-scroll-target="#visual-summary">Visual Summary</a></li>
  <li><a href="#change-history" id="toc-change-history" class="nav-link" data-scroll-target="#change-history">Change History</a></li>
  <li><a href="#monitoring-status" id="toc-monitoring-status" class="nav-link" data-scroll-target="#monitoring-status">Monitoring Status</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">TIGIT</h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  


</header>


<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Note
</div>
</div>
<div class="callout-body-container callout-body">
<p>TIGIT 타겟 임상시험 모니터링</p>
</div>
</div>
<section id="visual-summary" class="level2">
<h2 class="anchored" data-anchor-id="visual-summary">Visual Summary</h2>
<div class="tabset-margin-container"></div><div class="panel-tabset">
<ul class="nav nav-tabs" role="tablist"><li class="nav-item" role="presentation"><a class="nav-link active" id="tabset-1-1-tab" data-bs-toggle="tab" data-bs-target="#tabset-1-1" role="tab" aria-controls="tabset-1-1" aria-selected="true" href="">Status &amp; Phase</a></li><li class="nav-item" role="presentation"><a class="nav-link" id="tabset-1-2-tab" data-bs-toggle="tab" data-bs-target="#tabset-1-2" role="tab" aria-controls="tabset-1-2" aria-selected="false" href="">Top Sponsors</a></li></ul>
<div class="tab-content">
<div id="tabset-1-1" class="tab-pane active" role="tabpanel" aria-labelledby="tabset-1-1-tab">
<div id="6f79996e" class="cell" data-execution_count="1">
<div class="cell-output cell-output-display">
<div>            <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_SVG"></script><script type="text/javascript">if (window.MathJax && window.MathJax.Hub && window.MathJax.Hub.Config) {window.MathJax.Hub.Config({SVG: {font: "STIX-Web"}});}</script>                <script type="text/javascript">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>
        <script charset="utf-8" src="https://cdn.plot.ly/plotly-3.3.1.min.js" integrity="sha256-4rD3fugVb/nVJYUv5Ky3v+fYXoouHaBSP20WIJuEiWg=" crossorigin="anonymous"></script>                <div id="8f475fc1-cd55-4cf9-ba36-4b561c030854" class="plotly-graph-div" style="height:525px; width:100%;"></div>            <script type="text/javascript">                window.PLOTLYENV=window.PLOTLYENV || {};                                if (document.getElementById("8f475fc1-cd55-4cf9-ba36-4b561c030854")) {                    Plotly.newPlot(                        "8f475fc1-cd55-4cf9-ba36-4b561c030854",                        [{"hovertemplate":"Status=%{x}\u003cbr\u003eCount=%{y}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"RECRUITING","marker":{"color":"#636efa","pattern":{"shape":""}},"name":"RECRUITING","orientation":"v","showlegend":true,"textposition":"auto","x":["RECRUITING"],"xaxis":"x","y":{"dtype":"i1","bdata":"Ig=="},"yaxis":"y","type":"bar"},{"hovertemplate":"Status=%{x}\u003cbr\u003eCount=%{y}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"COMPLETED","marker":{"color":"#EF553B","pattern":{"shape":""}},"name":"COMPLETED","orientation":"v","showlegend":true,"textposition":"auto","x":["COMPLETED"],"xaxis":"x","y":{"dtype":"i1","bdata":"Ig=="},"yaxis":"y","type":"bar"},{"hovertemplate":"Status=%{x}\u003cbr\u003eCount=%{y}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"ACTIVE_NOT_RECRUITING","marker":{"color":"#00cc96","pattern":{"shape":""}},"name":"ACTIVE_NOT_RECRUITING","orientation":"v","showlegend":true,"textposition":"auto","x":["ACTIVE_NOT_RECRUITING"],"xaxis":"x","y":{"dtype":"i1","bdata":"Fg=="},"yaxis":"y","type":"bar"},{"hovertemplate":"Status=%{x}\u003cbr\u003eCount=%{y}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"UNKNOWN","marker":{"color":"#ab63fa","pattern":{"shape":""}},"name":"UNKNOWN","orientation":"v","showlegend":true,"textposition":"auto","x":["UNKNOWN"],"xaxis":"x","y":{"dtype":"i1","bdata":"DQ=="},"yaxis":"y","type":"bar"},{"hovertemplate":"Status=%{x}\u003cbr\u003eCount=%{y}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"TERMINATED","marker":{"color":"#FFA15A","pattern":{"shape":""}},"name":"TERMINATED","orientation":"v","showlegend":true,"textposition":"auto","x":["TERMINATED"],"xaxis":"x","y":{"dtype":"i1","bdata":"DA=="},"yaxis":"y","type":"bar"},{"hovertemplate":"Status=%{x}\u003cbr\u003eCount=%{y}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"NOT_YET_RECRUITING","marker":{"color":"#19d3f3","pattern":{"shape":""}},"name":"NOT_YET_RECRUITING","orientation":"v","showlegend":true,"textposition":"auto","x":["NOT_YET_RECRUITING"],"xaxis":"x","y":{"dtype":"i1","bdata":"Cw=="},"yaxis":"y","type":"bar"},{"hovertemplate":"Status=%{x}\u003cbr\u003eCount=%{y}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"WITHDRAWN","marker":{"color":"#FF6692","pattern":{"shape":""}},"name":"WITHDRAWN","orientation":"v","showlegend":true,"textposition":"auto","x":["WITHDRAWN"],"xaxis":"x","y":{"dtype":"i1","bdata":"Bg=="},"yaxis":"y","type":"bar"},{"hovertemplate":"Status=%{x}\u003cbr\u003eCount=%{y}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"ENROLLING_BY_INVITATION","marker":{"color":"#B6E880","pattern":{"shape":""}},"name":"ENROLLING_BY_INVITATION","orientation":"v","showlegend":true,"textposition":"auto","x":["ENROLLING_BY_INVITATION"],"xaxis":"x","y":{"dtype":"i1","bdata":"AQ=="},"yaxis":"y","type":"bar"}],                        {"template":{"data":{"barpolar":[{"marker":{"line":{"color":"white","width":0.5},"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"barpolar"}],"bar":[{"error_x":{"color":"#2a3f5f"},"error_y":{"color":"#2a3f5f"},"marker":{"line":{"color":"white","width":0.5},"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"bar"}],"carpet":[{"aaxis":{"endlinecolor":"#2a3f5f","gridcolor":"#C8D4E3","linecolor":"#C8D4E3","minorgridcolor":"#C8D4E3","startlinecolor":"#2a3f5f"},"baxis":{"endlinecolor":"#2a3f5f","gridcolor":"#C8D4E3","linecolor":"#C8D4E3","minorgridcolor":"#C8D4E3","startlinecolor":"#2a3f5f"},"type":"carpet"}],"choropleth":[{"colorbar":{"outlinewidth":0,"ticks":""},"type":"choropleth"}],"contourcarpet":[{"colorbar":{"outlinewidth":0,"ticks":""},"type":"contourcarpet"}],"contour":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"contour"}],"heatmap":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"heatmap"}],"histogram2dcontour":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"histogram2dcontour"}],"histogram2d":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"histogram2d"}],"histogram":[{"marker":{"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"histogram"}],"mesh3d":[{"colorbar":{"outlinewidth":0,"ticks":""},"type":"mesh3d"}],"parcoords":[{"line":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"parcoords"}],"pie":[{"automargin":true,"type":"pie"}],"scatter3d":[{"line":{"colorbar":{"outlinewidth":0,"ticks":""}},"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatter3d"}],"scattercarpet":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattercarpet"}],"scattergeo":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattergeo"}],"scattergl":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattergl"}],"scattermapbox":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattermapbox"}],"scattermap":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattermap"}],"scatterpolargl":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatterpolargl"}],"scatterpolar":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatterpolar"}],"scatter":[{"fillpattern":{"fillmode":"overlay","size":10,"solidity":0.2},"type":"scatter"}],"scatterternary":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatterternary"}],"surface":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"surface"}],"table":[{"cells":{"fill":{"color":"#EBF0F8"},"line":{"color":"white"}},"header":{"fill":{"color":"#C8D4E3"},"line":{"color":"white"}},"type":"table"}]},"layout":{"annotationdefaults":{"arrowcolor":"#2a3f5f","arrowhead":0,"arrowwidth":1},"autotypenumbers":"strict","coloraxis":{"colorbar":{"outlinewidth":0,"ticks":""}},"colorscale":{"diverging":[[0,"#8e0152"],[0.1,"#c51b7d"],[0.2,"#de77ae"],[0.3,"#f1b6da"],[0.4,"#fde0ef"],[0.5,"#f7f7f7"],[0.6,"#e6f5d0"],[0.7,"#b8e186"],[0.8,"#7fbc41"],[0.9,"#4d9221"],[1,"#276419"]],"sequential":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"sequentialminus":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]},"colorway":["#636efa","#EF553B","#00cc96","#ab63fa","#FFA15A","#19d3f3","#FF6692","#B6E880","#FF97FF","#FECB52"],"font":{"color":"#2a3f5f"},"geo":{"bgcolor":"white","lakecolor":"white","landcolor":"white","showlakes":true,"showland":true,"subunitcolor":"#C8D4E3"},"hoverlabel":{"align":"left"},"hovermode":"closest","mapbox":{"style":"light"},"margin":{"b":0,"l":0,"r":0,"t":30},"paper_bgcolor":"white","plot_bgcolor":"white","polar":{"angularaxis":{"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":""},"bgcolor":"white","radialaxis":{"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":""}},"scene":{"xaxis":{"backgroundcolor":"white","gridcolor":"#DFE8F3","gridwidth":2,"linecolor":"#EBF0F8","showbackground":true,"ticks":"","zerolinecolor":"#EBF0F8"},"yaxis":{"backgroundcolor":"white","gridcolor":"#DFE8F3","gridwidth":2,"linecolor":"#EBF0F8","showbackground":true,"ticks":"","zerolinecolor":"#EBF0F8"},"zaxis":{"backgroundcolor":"white","gridcolor":"#DFE8F3","gridwidth":2,"linecolor":"#EBF0F8","showbackground":true,"ticks":"","zerolinecolor":"#EBF0F8"}},"shapedefaults":{"line":{"color":"#2a3f5f"}},"ternary":{"aaxis":{"gridcolor":"#DFE8F3","linecolor":"#A2B1C6","ticks":""},"baxis":{"gridcolor":"#DFE8F3","linecolor":"#A2B1C6","ticks":""},"bgcolor":"white","caxis":{"gridcolor":"#DFE8F3","linecolor":"#A2B1C6","ticks":""}},"title":{"x":0.05},"xaxis":{"automargin":true,"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":"","title":{"standoff":15},"zerolinecolor":"#EBF0F8","zerolinewidth":2},"yaxis":{"automargin":true,"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":"","title":{"standoff":15},"zerolinecolor":"#EBF0F8","zerolinewidth":2}}},"xaxis":{"anchor":"y","domain":[0.0,1.0],"title":{"text":"Status"},"categoryorder":"array","categoryarray":["RECRUITING","COMPLETED","ACTIVE_NOT_RECRUITING","UNKNOWN","TERMINATED","NOT_YET_RECRUITING","WITHDRAWN","ENROLLING_BY_INVITATION"]},"yaxis":{"anchor":"x","domain":[0.0,1.0],"title":{"text":"Count"}},"legend":{"title":{"text":"Status"},"tracegroupgap":0},"title":{"text":"Study Status Distribution"},"barmode":"relative","showlegend":false},                        {"responsive": true}                    ).then(function(){
                            
var gd = document.getElementById('8f475fc1-cd55-4cf9-ba36-4b561c030854');
var x = new MutationObserver(function (mutations, observer) {{
        var display = window.getComputedStyle(gd).display;
        if (!display || display === 'none') {{
            console.log([gd, 'removed!']);
            Plotly.purge(gd);
            observer.disconnect();
        }}
}});

// Listen for the removal of the full notebook cells
var notebookContainer = gd.closest('#notebook-container');
if (notebookContainer) {{
    x.observe(notebookContainer, {childList: true});
}}

// Listen for the clearing of the current output cell
var outputEl = gd.closest('.output');
if (outputEl) {{
    x.observe(outputEl, {childList: true});
}}

                        })                };            </script>        </div>
</div>
</div>
<div id="c260c690" class="cell" data-execution_count="2">
<div class="cell-output cell-output-display">
<div>            <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_SVG"></script><script type="text/javascript">if (window.MathJax && window.MathJax.Hub && window.MathJax.Hub.Config) {window.MathJax.Hub.Config({SVG: {font: "STIX-Web"}});}</script>                <script type="text/javascript">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>
        <script charset="utf-8" src="https://cdn.plot.ly/plotly-3.3.1.min.js" integrity="sha256-4rD3fugVb/nVJYUv5Ky3v+fYXoouHaBSP20WIJuEiWg=" crossorigin="anonymous"></script>                <div id="17c16580-9f86-4fe4-9e5e-0b2a94e3c5d5" class="plotly-graph-div" style="height:525px; width:100%;"></div>            <script type="text/javascript">                window.PLOTLYENV=window.PLOTLYENV || {};                                if (document.getElementById("17c16580-9f86-4fe4-9e5e-0b2a94e3c5d5")) {                    Plotly.newPlot(                        "17c16580-9f86-4fe4-9e5e-0b2a94e3c5d5",                        [{"domain":{"x":[0.0,1.0],"y":[0.0,1.0]},"hole":0.4,"hovertemplate":"Phase=%{label}\u003cbr\u003eCount=%{value}\u003cextra\u003e\u003c\u002fextra\u003e","labels":["PHASE2","PHASE1","PHASE3","EARLY_PHASE1","PHASE4"],"legendgroup":"","name":"","showlegend":true,"values":{"dtype":"i1","bdata":"QjQPAgE="},"type":"pie"}],                        {"template":{"data":{"barpolar":[{"marker":{"line":{"color":"white","width":0.5},"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"barpolar"}],"bar":[{"error_x":{"color":"#2a3f5f"},"error_y":{"color":"#2a3f5f"},"marker":{"line":{"color":"white","width":0.5},"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"bar"}],"carpet":[{"aaxis":{"endlinecolor":"#2a3f5f","gridcolor":"#C8D4E3","linecolor":"#C8D4E3","minorgridcolor":"#C8D4E3","startlinecolor":"#2a3f5f"},"baxis":{"endlinecolor":"#2a3f5f","gridcolor":"#C8D4E3","linecolor":"#C8D4E3","minorgridcolor":"#C8D4E3","startlinecolor":"#2a3f5f"},"type":"carpet"}],"choropleth":[{"colorbar":{"outlinewidth":0,"ticks":""},"type":"choropleth"}],"contourcarpet":[{"colorbar":{"outlinewidth":0,"ticks":""},"type":"contourcarpet"}],"contour":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"contour"}],"heatmap":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"heatmap"}],"histogram2dcontour":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"histogram2dcontour"}],"histogram2d":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"histogram2d"}],"histogram":[{"marker":{"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"histogram"}],"mesh3d":[{"colorbar":{"outlinewidth":0,"ticks":""},"type":"mesh3d"}],"parcoords":[{"line":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"parcoords"}],"pie":[{"automargin":true,"type":"pie"}],"scatter3d":[{"line":{"colorbar":{"outlinewidth":0,"ticks":""}},"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatter3d"}],"scattercarpet":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattercarpet"}],"scattergeo":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattergeo"}],"scattergl":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattergl"}],"scattermapbox":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattermapbox"}],"scattermap":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattermap"}],"scatterpolargl":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatterpolargl"}],"scatterpolar":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatterpolar"}],"scatter":[{"fillpattern":{"fillmode":"overlay","size":10,"solidity":0.2},"type":"scatter"}],"scatterternary":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatterternary"}],"surface":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"surface"}],"table":[{"cells":{"fill":{"color":"#EBF0F8"},"line":{"color":"white"}},"header":{"fill":{"color":"#C8D4E3"},"line":{"color":"white"}},"type":"table"}]},"layout":{"annotationdefaults":{"arrowcolor":"#2a3f5f","arrowhead":0,"arrowwidth":1},"autotypenumbers":"strict","coloraxis":{"colorbar":{"outlinewidth":0,"ticks":""}},"colorscale":{"diverging":[[0,"#8e0152"],[0.1,"#c51b7d"],[0.2,"#de77ae"],[0.3,"#f1b6da"],[0.4,"#fde0ef"],[0.5,"#f7f7f7"],[0.6,"#e6f5d0"],[0.7,"#b8e186"],[0.8,"#7fbc41"],[0.9,"#4d9221"],[1,"#276419"]],"sequential":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"sequentialminus":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]},"colorway":["#636efa","#EF553B","#00cc96","#ab63fa","#FFA15A","#19d3f3","#FF6692","#B6E880","#FF97FF","#FECB52"],"font":{"color":"#2a3f5f"},"geo":{"bgcolor":"white","lakecolor":"white","landcolor":"white","showlakes":true,"showland":true,"subunitcolor":"#C8D4E3"},"hoverlabel":{"align":"left"},"hovermode":"closest","mapbox":{"style":"light"},"margin":{"b":0,"l":0,"r":0,"t":30},"paper_bgcolor":"white","plot_bgcolor":"white","polar":{"angularaxis":{"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":""},"bgcolor":"white","radialaxis":{"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":""}},"scene":{"xaxis":{"backgroundcolor":"white","gridcolor":"#DFE8F3","gridwidth":2,"linecolor":"#EBF0F8","showbackground":true,"ticks":"","zerolinecolor":"#EBF0F8"},"yaxis":{"backgroundcolor":"white","gridcolor":"#DFE8F3","gridwidth":2,"linecolor":"#EBF0F8","showbackground":true,"ticks":"","zerolinecolor":"#EBF0F8"},"zaxis":{"backgroundcolor":"white","gridcolor":"#DFE8F3","gridwidth":2,"linecolor":"#EBF0F8","showbackground":true,"ticks":"","zerolinecolor":"#EBF0F8"}},"shapedefaults":{"line":{"color":"#2a3f5f"}},"ternary":{"aaxis":{"gridcolor":"#DFE8F3","linecolor":"#A2B1C6","ticks":""},"baxis":{"gridcolor":"#DFE8F3","linecolor":"#A2B1C6","ticks":""},"bgcolor":"white","caxis":{"gridcolor":"#DFE8F3","linecolor":"#A2B1C6","ticks":""}},"title":{"x":0.05},"xaxis":{"automargin":true,"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":"","title":{"standoff":15},"zerolinecolor":"#EBF0F8","zerolinewidth":2},"yaxis":{"automargin":true,"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":"","title":{"standoff":15},"zerolinecolor":"#EBF0F8","zerolinewidth":2}}},"legend":{"tracegroupgap":0},"title":{"text":"Trial Phase Distribution"}},                        {"responsive": true}                    ).then(function(){
                            
var gd = document.getElementById('17c16580-9f86-4fe4-9e5e-0b2a94e3c5d5');
var x = new MutationObserver(function (mutations, observer) {{
        var display = window.getComputedStyle(gd).display;
        if (!display || display === 'none') {{
            console.log([gd, 'removed!']);
            Plotly.purge(gd);
            observer.disconnect();
        }}
}});

// Listen for the removal of the full notebook cells
var notebookContainer = gd.closest('#notebook-container');
if (notebookContainer) {{
    x.observe(notebookContainer, {childList: true});
}}

// Listen for the clearing of the current output cell
var outputEl = gd.closest('.output');
if (outputEl) {{
    x.observe(outputEl, {childList: true});
}}

                        })                };            </script>        </div>
</div>
</div>
</div>
<div id="tabset-1-2" class="tab-pane" role="tabpanel" aria-labelledby="tabset-1-2-tab">
<div id="bdc88b5c" class="cell" data-execution_count="3">
<div class="cell-output cell-output-display">
<div>            <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_SVG"></script><script type="text/javascript">if (window.MathJax && window.MathJax.Hub && window.MathJax.Hub.Config) {window.MathJax.Hub.Config({SVG: {font: "STIX-Web"}});}</script>                <script type="text/javascript">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>
        <script charset="utf-8" src="https://cdn.plot.ly/plotly-3.3.1.min.js" integrity="sha256-4rD3fugVb/nVJYUv5Ky3v+fYXoouHaBSP20WIJuEiWg=" crossorigin="anonymous"></script>                <div id="ef437f06-d6db-4734-95a0-af61e79579fc" class="plotly-graph-div" style="height:525px; width:100%;"></div>            <script type="text/javascript">                window.PLOTLYENV=window.PLOTLYENV || {};                                if (document.getElementById("ef437f06-d6db-4734-95a0-af61e79579fc")) {                    Plotly.newPlot(                        "ef437f06-d6db-4734-95a0-af61e79579fc",                        [{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"AstraZeneca","marker":{"color":"#636efa","pattern":{"shape":""}},"name":"AstraZeneca","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"DQ=="},"xaxis":"x","y":["AstraZeneca"],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Hoffmann-La Roche","marker":{"color":"#EF553B","pattern":{"shape":""}},"name":"Hoffmann-La Roche","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"CA=="},"xaxis":"x","y":["Hoffmann-La Roche"],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"BeiGene","marker":{"color":"#00cc96","pattern":{"shape":""}},"name":"BeiGene","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"Bw=="},"xaxis":"x","y":["BeiGene"],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Arcus Biosciences, Inc.","marker":{"color":"#ab63fa","pattern":{"shape":""}},"name":"Arcus Biosciences, Inc.","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"BQ=="},"xaxis":"x","y":["Arcus Biosciences, Inc."],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Shanghai Henlius Biotech","marker":{"color":"#FFA15A","pattern":{"shape":""}},"name":"Shanghai Henlius Biotech","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"BA=="},"xaxis":"x","y":["Shanghai Henlius Biotech"],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Merck Sharp & Dohme LLC","marker":{"color":"#19d3f3","pattern":{"shape":""}},"name":"Merck Sharp & Dohme LLC","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"BA=="},"xaxis":"x","y":["Merck Sharp & Dohme LLC"],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Innovent Biologics (Suzhou) Co. Ltd.","marker":{"color":"#FF6692","pattern":{"shape":""}},"name":"Innovent Biologics (Suzhou) Co. Ltd.","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"Aw=="},"xaxis":"x","y":["Innovent Biologics (Suzhou) Co. Ltd."],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Compugen Ltd","marker":{"color":"#B6E880","pattern":{"shape":""}},"name":"Compugen Ltd","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"Aw=="},"xaxis":"x","y":["Compugen Ltd"],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Assistance Publique - H\u00f4pitaux de Paris","marker":{"color":"#FF97FF","pattern":{"shape":""}},"name":"Assistance Publique - H\u00f4pitaux de Paris","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"Aw=="},"xaxis":"x","y":["Assistance Publique - H\u00f4pitaux de Paris"],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Biotheus Inc.","marker":{"color":"#FECB52","pattern":{"shape":""}},"name":"Biotheus Inc.","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"Ag=="},"xaxis":"x","y":["Biotheus Inc."],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Assiut University","marker":{"color":"#636efa","pattern":{"shape":""}},"name":"Assiut University","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"Ag=="},"xaxis":"x","y":["Assiut University"],"yaxis":"y","type":"bar"},{"hovertemplate":"Sponsor=%{y}\u003cbr\u003eCount=%{x}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Shanghai Junshi Bioscience Co., Ltd.","marker":{"color":"#EF553B","pattern":{"shape":""}},"name":"Shanghai Junshi Bioscience Co., Ltd.","orientation":"h","showlegend":true,"textposition":"auto","x":{"dtype":"i1","bdata":"Ag=="},"xaxis":"x","y":["Shanghai Junshi Bioscience Co., Ltd."],"yaxis":"y","type":"bar"}],                        {"template":{"data":{"barpolar":[{"marker":{"line":{"color":"white","width":0.5},"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"barpolar"}],"bar":[{"error_x":{"color":"#2a3f5f"},"error_y":{"color":"#2a3f5f"},"marker":{"line":{"color":"white","width":0.5},"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"bar"}],"carpet":[{"aaxis":{"endlinecolor":"#2a3f5f","gridcolor":"#C8D4E3","linecolor":"#C8D4E3","minorgridcolor":"#C8D4E3","startlinecolor":"#2a3f5f"},"baxis":{"endlinecolor":"#2a3f5f","gridcolor":"#C8D4E3","linecolor":"#C8D4E3","minorgridcolor":"#C8D4E3","startlinecolor":"#2a3f5f"},"type":"carpet"}],"choropleth":[{"colorbar":{"outlinewidth":0,"ticks":""},"type":"choropleth"}],"contourcarpet":[{"colorbar":{"outlinewidth":0,"ticks":""},"type":"contourcarpet"}],"contour":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"contour"}],"heatmap":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"heatmap"}],"histogram2dcontour":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"histogram2dcontour"}],"histogram2d":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"histogram2d"}],"histogram":[{"marker":{"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"histogram"}],"mesh3d":[{"colorbar":{"outlinewidth":0,"ticks":""},"type":"mesh3d"}],"parcoords":[{"line":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"parcoords"}],"pie":[{"automargin":true,"type":"pie"}],"scatter3d":[{"line":{"colorbar":{"outlinewidth":0,"ticks":""}},"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatter3d"}],"scattercarpet":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattercarpet"}],"scattergeo":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattergeo"}],"scattergl":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattergl"}],"scattermapbox":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattermapbox"}],"scattermap":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scattermap"}],"scatterpolargl":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatterpolargl"}],"scatterpolar":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatterpolar"}],"scatter":[{"fillpattern":{"fillmode":"overlay","size":10,"solidity":0.2},"type":"scatter"}],"scatterternary":[{"marker":{"colorbar":{"outlinewidth":0,"ticks":""}},"type":"scatterternary"}],"surface":[{"colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"type":"surface"}],"table":[{"cells":{"fill":{"color":"#EBF0F8"},"line":{"color":"white"}},"header":{"fill":{"color":"#C8D4E3"},"line":{"color":"white"}},"type":"table"}]},"layout":{"annotationdefaults":{"arrowcolor":"#2a3f5f","arrowhead":0,"arrowwidth":1},"autotypenumbers":"strict","coloraxis":{"colorbar":{"outlinewidth":0,"ticks":""}},"colorscale":{"diverging":[[0,"#8e0152"],[0.1,"#c51b7d"],[0.2,"#de77ae"],[0.3,"#f1b6da"],[0.4,"#fde0ef"],[0.5,"#f7f7f7"],[0.6,"#e6f5d0"],[0.7,"#b8e186"],[0.8,"#7fbc41"],[0.9,"#4d9221"],[1,"#276419"]],"sequential":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"sequentialminus":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]},"colorway":["#636efa","#EF553B","#00cc96","#ab63fa","#FFA15A","#19d3f3","#FF6692","#B6E880","#FF97FF","#FECB52"],"font":{"color":"#2a3f5f"},"geo":{"bgcolor":"white","lakecolor":"white","landcolor":"white","showlakes":true,"showland":true,"subunitcolor":"#C8D4E3"},"hoverlabel":{"align":"left"},"hovermode":"closest","mapbox":{"style":"light"},"margin":{"b":0,"l":0,"r":0,"t":30},"paper_bgcolor":"white","plot_bgcolor":"white","polar":{"angularaxis":{"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":""},"bgcolor":"white","radialaxis":{"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":""}},"scene":{"xaxis":{"backgroundcolor":"white","gridcolor":"#DFE8F3","gridwidth":2,"linecolor":"#EBF0F8","showbackground":true,"ticks":"","zerolinecolor":"#EBF0F8"},"yaxis":{"backgroundcolor":"white","gridcolor":"#DFE8F3","gridwidth":2,"linecolor":"#EBF0F8","showbackground":true,"ticks":"","zerolinecolor":"#EBF0F8"},"zaxis":{"backgroundcolor":"white","gridcolor":"#DFE8F3","gridwidth":2,"linecolor":"#EBF0F8","showbackground":true,"ticks":"","zerolinecolor":"#EBF0F8"}},"shapedefaults":{"line":{"color":"#2a3f5f"}},"ternary":{"aaxis":{"gridcolor":"#DFE8F3","linecolor":"#A2B1C6","ticks":""},"baxis":{"gridcolor":"#DFE8F3","linecolor":"#A2B1C6","ticks":""},"bgcolor":"white","caxis":{"gridcolor":"#DFE8F3","linecolor":"#A2B1C6","ticks":""}},"title":{"x":0.05},"xaxis":{"automargin":true,"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":"","title":{"standoff":15},"zerolinecolor":"#EBF0F8","zerolinewidth":2},"yaxis":{"automargin":true,"gridcolor":"#EBF0F8","linecolor":"#EBF0F8","ticks":"","title":{"standoff":15},"zerolinecolor":"#EBF0F8","zerolinewidth":2}}},"xaxis":{"anchor":"y","domain":[0.0,1.0],"title":{"text":"Count"}},"yaxis":{"anchor":"x","domain":[0.0,1.0],"title":{"text":"Sponsor"},"categoryorder":"total ascending","categoryarray":["Shanghai Junshi Bioscience Co., Ltd.","Assiut University","Biotheus Inc.","Assistance Publique - H\u00f4pitaux de Paris","Compugen Ltd","Innovent Biologics (Suzhou) Co. Ltd.","Merck Sharp & Dohme LLC","Shanghai Henlius Biotech","Arcus Biosciences, Inc.","BeiGene","Hoffmann-La Roche","AstraZeneca"]},"legend":{"title":{"text":"Sponsor"},"tracegroupgap":0},"title":{"text":"Top Lead Sponsors (by Number of Trials)"},"barmode":"relative","showlegend":false},                        {"responsive": true}                    ).then(function(){
                            
var gd = document.getElementById('ef437f06-d6db-4734-95a0-af61e79579fc');
var x = new MutationObserver(function (mutations, observer) {{
        var display = window.getComputedStyle(gd).display;
        if (!display || display === 'none') {{
            console.log([gd, 'removed!']);
            Plotly.purge(gd);
            observer.disconnect();
        }}
}});

// Listen for the removal of the full notebook cells
var notebookContainer = gd.closest('#notebook-container');
if (notebookContainer) {{
    x.observe(notebookContainer, {childList: true});
}}

// Listen for the clearing of the current output cell
var outputEl = gd.closest('.output');
if (outputEl) {{
    x.observe(outputEl, {childList: true});
}}

                        })                };            </script>        </div>
</div>
</div>
</div>
</div>
</div>
<hr>
</section>
<section id="change-history" class="level2">
<h2 class="anchored" data-anchor-id="change-history">Change History</h2>
<div class="tabset-margin-container"></div><div class="panel-tabset">
<ul class="nav nav-tabs" role="tablist"><li class="nav-item" role="presentation"><a class="nav-link active" id="tabset-2-1-tab" data-bs-toggle="tab" data-bs-target="#tabset-2-1" role="tab" aria-controls="tabset-2-1" aria-selected="true" href="">Target Milestones</a></li><li class="nav-item" role="presentation"><a class="nav-link" id="tabset-2-2-tab" data-bs-toggle="tab" data-bs-target="#tabset-2-2" role="tab" aria-controls="tabset-2-2" aria-selected="false" href="">Trial Changes</a></li></ul>
<div class="tab-content">
<div id="tabset-2-1" class="tab-pane active" role="tabpanel" aria-labelledby="tabset-2-1-tab">
<p><strong>Date:</strong> 2026-02-19 01:00:02</p>
<p>Changes detected in 3 trials: NCT06754501, NCT05775159, NCT05665595</p>
<hr>
<p><strong>Date:</strong> 2026-02-16 21:08:12</p>
<p>Changes detected in 3 trials: NCT05805501, NCT05123482, NCT06627647</p>
<hr>
<p><strong>Date:</strong> 2026-02-12 14:01:41</p>
<p>Changes detected in 3 trials: NCT05574335, NCT07221253, NCT06989112</p>
<hr>
<p><strong>Date:</strong> 2026-02-10 07:03:54</p>
<p>Changes detected in 2 trials: NCT07115043, NCT07098338</p>
<hr>
<p><strong>Date:</strong> 2026-02-05 15:27:28</p>
<p>Initial data collection: 133 trials found.</p>
<hr>
</div>
<div id="tabset-2-2" class="tab-pane" role="tabpanel" aria-labelledby="tabset-2-2-tab">
<section id="nct06754501" class="level4">
<h4 class="anchored" data-anchor-id="nct06754501">NCT06754501</h4>
<p><strong>Date:</strong> 2026-02-19 01:00:00</p>
<p>Field <code>statusModule.statusVerifiedDate</code> changed from <code>2025-08</code> to <code>2026-02</code> Field <code>statusModule.overallStatus</code> changed from <code>RECRUITING</code> to <code>ACTIVE_NOT_RECRUITING</code> Field <code>statusModule.lastUpdateSubmitDate</code> changed from <code>2025-10-01</code> to <code>2026-02-16</code> Field <code>statusModule.lastUpdatePostDateStruct.date</code> changed from <code>2025-10-07</code> to <code>2026-02-18</code> Field <code>designModule.enrollmentInfo.count</code> changed from <code>35</code> to <code>4</code> Field <code>designModule.enrollmentInfo.type</code> changed from <code>ESTIMATED</code> to <code>ACTUAL</code> Field removed: <code>root['statusModule']['expandedAccessInfo']</code> Field removed: <code>root['contactsLocationsModule']['centralContacts']</code> Field removed: <code>root['contactsLocationsModule']['locations'][0]['status']</code> Field removed: <code>root['contactsLocationsModule']['locations'][0]['contacts']</code></p>
<hr>
</section>
<section id="nct05805501" class="level4">
<h4 class="anchored" data-anchor-id="nct05805501">NCT05805501</h4>
<p><strong>Date:</strong> 2026-02-16 21:08:09</p>
<p>Field <code>statusModule.statusVerifiedDate</code> changed from <code>2025-11</code> to <code>2026-02</code> Field <code>statusModule.primaryCompletionDateStruct.date</code> changed from <code>2026-07-31</code> to <code>2026-10-31</code> Field <code>statusModule.completionDateStruct.date</code> changed from <code>2026-07-31</code> to <code>2026-10-31</code> Field <code>statusModule.lastUpdateSubmitDate</code> changed from <code>2025-11-12</code> to <code>2026-02-10</code> Field <code>statusModule.lastUpdatePostDateStruct.date</code> changed from <code>2025-11-13</code> to <code>2026-02-12</code></p>
<hr>
</section>
<section id="nct07115043" class="level4">
<h4 class="anchored" data-anchor-id="nct07115043">NCT07115043</h4>
<p><strong>Date:</strong> 2026-02-10 07:03:45</p>
<p>Field <code>statusModule.statusVerifiedDate</code> changed from <code>2025-12</code> to <code>2026-02</code> Field <code>statusModule.lastUpdateSubmitDate</code> changed from <code>2025-12-18</code> to <code>2026-02-04</code> Field <code>statusModule.lastUpdatePostDateStruct.date</code> changed from <code>2025-12-19</code> to <code>2026-02-05</code> Field <code>contactsLocationsModule.locations.[1]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[3]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code></p>
<hr>
</section>
<section id="nct05123482" class="level4">
<h4 class="anchored" data-anchor-id="nct05123482">NCT05123482</h4>
<p><strong>Date:</strong> 2026-02-16 21:08:10</p>
<p>Field <code>statusModule.statusVerifiedDate</code> changed from <code>2025-11</code> to <code>2026-02</code> Field <code>statusModule.lastUpdateSubmitDate</code> changed from <code>2025-12-02</code> to <code>2026-02-11</code> Field <code>statusModule.lastUpdatePostDateStruct.date</code> changed from <code>2025-12-08</code> to <code>2026-02-13</code> Field <code>contactsLocationsModule.locations.[0]status</code> changed from <code>RECRUITING</code> to <code>COMPLETED</code> Field <code>contactsLocationsModule.locations.[1]status</code> changed from <code>RECRUITING</code> to <code>COMPLETED</code> Field <code>contactsLocationsModule.locations.[18]status</code> changed from <code>WITHDRAWN</code> to <code>NOT_YET_RECRUITING</code> Field <code>contactsLocationsModule.locations.[18]city</code> changed from <code>South Brisbane</code> to <code>Taichung</code> Field <code>contactsLocationsModule.locations.[18]zip</code> changed from <code>4101</code> to <code>40705</code> Field <code>contactsLocationsModule.locations.[18]country</code> changed from <code>Australia</code> to <code>Taiwan</code> Field <code>contactsLocationsModule.locations.[18]geoPoint.lat</code> changed from <code>-27.48034</code> to <code>24.1469</code> Field <code>contactsLocationsModule.locations.[18]geoPoint.lon</code> changed from <code>153.02049</code> to <code>120.6839</code></p>
<hr>
</section>
<section id="nct05775159" class="level4">
<h4 class="anchored" data-anchor-id="nct05775159">NCT05775159</h4>
<p><strong>Date:</strong> 2026-02-19 01:00:01</p>
<p>Field <code>statusModule.statusVerifiedDate</code> changed from <code>2025-11</code> to <code>2026-02</code> Field <code>statusModule.lastUpdateSubmitDate</code> changed from <code>2025-11-12</code> to <code>2026-02-16</code> Field <code>statusModule.lastUpdatePostDateStruct.date</code> changed from <code>2025-11-13</code> to <code>2026-02-18</code></p>
<hr>
</section>
<section id="nct05574335" class="level4">
<h4 class="anchored" data-anchor-id="nct05574335">NCT05574335</h4>
<p><strong>Date:</strong> 2026-02-12 14:01:39</p>
<p>Field <code>statusModule.statusVerifiedDate</code> changed from <code>2026-01</code> to <code>2026-02</code> Field <code>statusModule.lastUpdateSubmitDate</code> changed from <code>2026-01-05</code> to <code>2026-02-10</code> Field <code>statusModule.lastUpdatePostDateStruct.date</code> changed from <code>2026-01-06</code> to <code>2026-02-11</code></p>
<hr>
</section>
<section id="nct07098338" class="level4">
<h4 class="anchored" data-anchor-id="nct07098338">NCT07098338</h4>
<p><strong>Date:</strong> 2026-02-10 07:03:50</p>
<p>Field <code>statusModule.statusVerifiedDate</code> changed from <code>2025-09</code> to <code>2026-01</code> Field <code>statusModule.primaryCompletionDateStruct.date</code> changed from <code>2027-03-21</code> to <code>2029-04-06</code> Field <code>statusModule.lastUpdateSubmitDate</code> changed from <code>2025-09-25</code> to <code>2026-02-03</code> Field <code>statusModule.lastUpdatePostDateStruct.date</code> changed from <code>2025-09-30</code> to <code>2026-02-05</code> Field <code>descriptionModule.detailedDescription</code> changed from `The master protocol will include 3 sub-studies, each focused on a specific disease population.</p>
<ul>
<li>Sub-study 1 will investigate rilvegostomig± ramucirumab in 1L non-actionable genomic alterations (AGA) NSCLC with PD-L1 ≥50%.</li>
<li>Sub-study 2 will investigate rilvegostomig + ramucirumab in 1L non-actionable genomic alterations (AGA) NSCLC with PD-L1 1-49%.</li>
<li>Sub-study 3 will investigate Dato-DXd + ramucirumab ± rilvegostomig in 2L AGA+</li>
</ul>
<p>Each sub-study may include 2 parts (unless stated in the individual sub study protocols): Part A: one or more Safety Run-in cohort(s), and Part B: one or more Dose Expansion cohort(s).<code>to</code>The master protocol will include 3 sub-studies, each focused on a specific disease population.</p>
<ul>
<li>Sub-study 1 will investigate rilvegostomig± ramucirumab in 1L non-actionable genomic alterations (AGA) NSCLC with PD-L1 ≥50%.</li>
<li>Sub-study 2 will investigate rilvegostomig + ramucirumab in 1L non-actionable genomic alterations (AGA) NSCLC with PD-L1 1-49%.</li>
<li>Sub-study 3 will investigate Dato-DXd + ramucirumab ± rilvegostomig in 2/3L AGA+</li>
</ul>
<p>Each sub-study may include 2 parts (unless stated in the individual sub study protocols): Part A: one or more Safety Run-in cohort(s), and Part B: one or more Dose Expansion cohort(s).<code>Field</code>outcomesModule.primaryOutcomes.[1]description<code>changed from</code>ORR is defined as the proportion of participants who have a confirmed CR (complete response) or confirmed PR (partial response), determined by the Investigator at local site per RECIST 1.1<code>to</code>ORR is defined as the proportion of participants who have a confirmed CR (complete response) or confirmed PR (partial response) per RECIST 1.1<code>Field</code>outcomesModule.secondaryOutcomes.[2]description<code>changed from</code>PFS is defined as the time from the start of treatment until the date of objective disease progression or death (by any cause in the absence of progression) per RECIST 1.1 as assessed by Investigator.<code>to</code>PFS is defined as the time from the start of treatment until the date of objective disease progression or death (by any cause in the absence of progression) per RECIST 1.1.<code>Field</code>contactsLocationsModule.locations.[10]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[11]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[12]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[14]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[16]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[17]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[19]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[26]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[28]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[29]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[32]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[33]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[34]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[36]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[37]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[38]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[40]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[41]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[42]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[43]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[44]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[46]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[48]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[50]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>contactsLocationsModule.locations.[51]status<code>changed from</code>NOT_YET_RECRUITING<code>to</code>RECRUITING<code>Field</code>armsInterventionsModule.armGroups.[0]<code>changed from</code>{‘label’: ‘Sub-study 1, investigate rilvegostomig± ramucirumab in 1L non-AGA NSCLC with PD-L1 ≥50%’, ‘type’: ‘EXPERIMENTAL’, ‘description’: ‘Participants will receive rilvegostomig ± ramucirumab until RECIST 1.1-defined radiological progression as assessed by the investigator, unacceptable toxicity, withdrawal of consent, or other discontinuation criterion’, ‘interventionNames’: [‘Drug: Rilvegostomig’, ‘Drug: Ramucirumab’]}<code>to</code>{‘label’: ‘Sub-study 1, investigate rilvegostomig± ramucirumab in 1L non-AGA NSCLC with PD-L1 ≥50%’, ‘type’: ‘EXPERIMENTAL’, ‘description’: ‘Participants will receive rilvegostomig ± ramucirumab until RECIST 1.1-defined radiological progression, unacceptable toxicity, withdrawal of consent, or other discontinuation criterion’, ‘interventionNames’: [‘Drug: Rilvegostomig’, ‘Drug: Ramucirumab’]}<code>Field</code>armsInterventionsModule.interventions.[2]<code>changed from</code>{‘type’: ‘DRUG’, ‘name’: ‘Dato-DXd’, ‘description’: ‘Dato-DXd will be administered as IV infusion.’, ‘armGroupLabels’: [‘Sub-study 3, investigate Dato-DXd + ramucirumab ± rilvegostomig in 2L AGA+ NSCLC’], ‘otherNames’: [‘DS-1062’]}<code>to</code>{‘type’: ‘DRUG’, ‘name’: ‘Dato-DXd’, ‘description’: ‘Dato-DXd will be administered as IV infusion.’, ‘armGroupLabels’: [‘Sub-study 3, investigate Dato-DXd + ramucirumab ± rilvegostomig in 2/3L AGA+ NSCLC’], ‘otherNames’: [‘DS-1062’]}<code>Field</code>armsInterventionsModule.interventions.[0]<code>changed from</code>{‘type’: ‘DRUG’, ‘name’: ‘Rilvegostomig’, ‘description’: ‘Rilvegostomig will be administered as IV infusion.’, ‘armGroupLabels’: [‘Sub-study 1, investigate rilvegostomig± ramucirumab in 1L non-AGA NSCLC with PD-L1 ≥50%’, ‘Sub-study 2, investigate rilvegostomig + ramucirumab in 1L non-AGA NSCLC with PD-L1 1-49%’, ‘Sub-study 3, investigate Dato-DXd + ramucirumab ± rilvegostomig in 2L AGA+ NSCLC’], ‘otherNames’: [‘AZD2936’]}<code>to</code>{‘type’: ‘DRUG’, ‘name’: ‘Rilvegostomig’, ‘description’: ‘Rilvegostomig will be administered as IV infusion.’, ‘armGroupLabels’: [‘Sub-study 1, investigate rilvegostomig± ramucirumab in 1L non-AGA NSCLC with PD-L1 ≥50%’, ‘Sub-study 2, investigate rilvegostomig + ramucirumab in 1L non-AGA NSCLC with PD-L1 1-49%’, ‘Sub-study 3, investigate Dato-DXd + ramucirumab ± rilvegostomig in 2/3L AGA+ NSCLC’], ‘otherNames’: [‘AZD2936’]}<code>Field</code>armsInterventionsModule.armGroups.[2]<code>changed from</code>{‘label’: ‘Sub-study 3, investigate Dato-DXd + ramucirumab ± rilvegostomig in 2L AGA+ NSCLC’, ‘type’: ‘EXPERIMENTAL’, ‘description’: ‘Participants will receive Dato-DXd + ramucirumab ± rilvegostomig until RECIST 1.1-defined radiological progression as assessed by the investigator, unacceptable toxicity, withdrawal of consent, or other discontinuation criterion’, ‘interventionNames’: [‘Drug: Rilvegostomig’, ‘Drug: Ramucirumab’, ‘Drug: Dato-DXd’]}<code>to</code>{‘label’: ‘Sub-study 3, investigate Dato-DXd + ramucirumab ± rilvegostomig in 2/3L AGA+ NSCLC’, ‘type’: ‘EXPERIMENTAL’, ‘description’: ‘Participants will receive Dato-DXd + ramucirumab ± rilvegostomig until RECIST 1.1-defined radiological progression, unacceptable toxicity, withdrawal of consent, or other discontinuation criterion’, ‘interventionNames’: [‘Drug: Rilvegostomig’, ‘Drug: Ramucirumab’, ‘Drug: Dato-DXd’]}<code>Field</code>armsInterventionsModule.armGroups.[1]<code>changed from</code>{‘label’: ‘Sub-study 2, investigate rilvegostomig + ramucirumab in 1L non-AGA NSCLC with PD-L1 1-49%’, ‘type’: ‘EXPERIMENTAL’, ‘description’: ‘Participants will receive rilvegostomig + ramucirumab until RECIST 1.1-defined radiological progression as assessed by the investigator, unacceptable toxicity, withdrawal of consent, or other discontinuation criterion’, ‘interventionNames’: [‘Drug: Rilvegostomig’, ‘Drug: Ramucirumab’]}<code>to</code>{‘label’: ‘Sub-study 2, investigate rilvegostomig + ramucirumab in 1L non-AGA NSCLC with PD-L1 1-49%’, ‘type’: ‘EXPERIMENTAL’, ‘description’: ‘Participants will receive rilvegostomig + ramucirumab until RECIST 1.1-defined radiological progression, unacceptable toxicity, withdrawal of consent, or other discontinuation criterion’, ‘interventionNames’: [‘Drug: Rilvegostomig’, ‘Drug: Ramucirumab’]}<code>Field</code>armsInterventionsModule.interventions.[1]<code>changed from</code>{‘type’: ‘DRUG’, ‘name’: ‘Ramucirumab’, ‘description’: ‘Ramucirumab will be administered as IV infusion.’, ‘armGroupLabels’: [‘Sub-study 1, investigate rilvegostomig± ramucirumab in 1L non-AGA NSCLC with PD-L1 ≥50%’, ‘Sub-study 2, investigate rilvegostomig + ramucirumab in 1L non-AGA NSCLC with PD-L1 1-49%’, ‘Sub-study 3, investigate Dato-DXd + ramucirumab ± rilvegostomig in 2L AGA+ NSCLC’], ‘otherNames’: [‘Cyramza’]}<code>to</code>{‘type’: ‘DRUG’, ‘name’: ‘Ramucirumab’, ‘description’: ‘Ramucirumab will be administered as IV infusion.’, ‘armGroupLabels’: [‘Sub-study 1, investigate rilvegostomig± ramucirumab in 1L non-AGA NSCLC with PD-L1 ≥50%’, ‘Sub-study 2, investigate rilvegostomig + ramucirumab in 1L non-AGA NSCLC with PD-L1 1-49%’, ‘Sub-study 3, investigate Dato-DXd + ramucirumab ± rilvegostomig in 2/3L AGA+ NSCLC’], ‘otherNames’: [‘Cyramza’]}`</p>
<hr>
</section>
<section id="nct07221253" class="level4">
<h4 class="anchored" data-anchor-id="nct07221253">NCT07221253</h4>
<p><strong>Date:</strong> 2026-02-12 14:01:40</p>
<p>Field <code>statusModule.statusVerifiedDate</code> changed from <code>2025-12</code> to <code>2026-02</code> Field <code>statusModule.lastUpdateSubmitDate</code> changed from <code>2026-01-07</code> to <code>2026-02-09</code> Field <code>statusModule.lastUpdatePostDateStruct.date</code> changed from <code>2026-01-08</code> to <code>2026-02-10</code> Field <code>contactsLocationsModule.locations.[32]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[39]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[40]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[43]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[58]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>SUSPENDED</code> Field <code>contactsLocationsModule.locations.[89]city</code> changed from <code>Lichtenberg</code> to <code>Berlin</code> Field <code>contactsLocationsModule.locations.[89]geoPoint.lat</code> changed from <code>52.51395</code> to <code>52.52437</code> Field <code>contactsLocationsModule.locations.[89]geoPoint.lon</code> changed from <code>13.49975</code> to <code>13.41053</code> Field <code>contactsLocationsModule.locations.[103]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[131]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[138]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[141]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[143]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[145]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[147]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code></p>
<hr>
</section>
<section id="nct05665595" class="level4">
<h4 class="anchored" data-anchor-id="nct05665595">NCT05665595</h4>
<p><strong>Date:</strong> 2026-02-19 01:00:02</p>
<p>Minor formatting updates.</p>
<hr>
</section>
<section id="nct06989112" class="level4">
<h4 class="anchored" data-anchor-id="nct06989112">NCT06989112</h4>
<p><strong>Date:</strong> 2026-02-12 14:01:41</p>
<p>Field <code>statusModule.statusVerifiedDate</code> changed from <code>2026-01</code> to <code>2026-02</code> Field <code>statusModule.lastUpdateSubmitDate</code> changed from <code>2026-01-14</code> to <code>2026-02-09</code> Field <code>statusModule.lastUpdatePostDateStruct.date</code> changed from <code>2026-01-15</code> to <code>2026-02-10</code> Field <code>contactsLocationsModule.locations.[11]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[46]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[57]zip</code> changed from <code>53705</code> to <code>53792</code> Field <code>contactsLocationsModule.locations.[70]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[76]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[78]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[79]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[121]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[149]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[182]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[190]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[223]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[245]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code></p>
<hr>
</section>
<section id="nct06627647" class="level4">
<h4 class="anchored" data-anchor-id="nct06627647">NCT06627647</h4>
<p><strong>Date:</strong> 2026-02-16 21:08:12</p>
<p>Field <code>statusModule.statusVerifiedDate</code> changed from <code>2025-12</code> to <code>2026-02</code> Field <code>statusModule.lastUpdateSubmitDate</code> changed from <code>2025-12-19</code> to <code>2026-02-11</code> Field <code>statusModule.lastUpdatePostDateStruct.date</code> changed from <code>2025-12-22</code> to <code>2026-02-12</code> Field <code>contactsLocationsModule.locations.[16]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[23]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[179]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>WITHDRAWN</code> Field <code>contactsLocationsModule.locations.[183]status</code> changed from <code>RECRUITING</code> to <code>WITHDRAWN</code> Field <code>contactsLocationsModule.locations.[196]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[202]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>RECRUITING</code> Field <code>contactsLocationsModule.locations.[232]status</code> changed from <code>NOT_YET_RECRUITING</code> to <code>SUSPENDED</code></p>
<hr>
</section>
</div>
</div>
</div>
<hr>
<p><a href="../data/targets/tigit/all_trials_raw.csv" class="btn btn-primary" role="button">📥 Download Full Data (CSV)</a> <a href="../data/targets/tigit/status_summary.csv" class="btn btn-outline-secondary" role="button">📥 Download Status Summary (CSV)</a></p>
<hr>
</section>
<section id="monitoring-status" class="level2">
<h2 class="anchored" data-anchor-id="monitoring-status">Monitoring Status</h2>
<table class="caption-top table">
<thead>
<tr class="header">
<th>Trial ID</th>
<th>Sponsor</th>
<th>Update</th>
<th>Status</th>
<th>Conditions</th>
<th>Phases</th>
<th>Start</th>
<th>End</th>
<th>Enroll</th>
<th>Last Updated</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05483400">NCT05483400</a></td>
<td>University Medical Center Groningen</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Head and Neck Neoplasms, MSI-H Cancer, Melanoma</td>
<td>PHASE2</td>
<td>2023-10-18</td>
<td>2027-09</td>
<td>97</td>
<td>2025-03-28</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT03119428">NCT03119428</a></td>
<td>OncoMed Pharmaceuticals, Inc.</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Locally Advanced Cancer, Metastatic Cancer</td>
<td>PHASE1</td>
<td>2017-05-02</td>
<td>2019-05-15</td>
<td>33</td>
<td>2020-08-10</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04150965">NCT04150965</a></td>
<td>Multiple Myeloma Research Consortium</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Multiple Myeloma, Relapsed Refractory Multiple Myeloma</td>
<td>PHASE1, PHASE2</td>
<td>2020-07-10</td>
<td>2024-08-30</td>
<td>14</td>
<td>2025-02-12</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT07171307">NCT07171307</a></td>
<td>Instituto de Oftalmología Fundación Conde de Valenciana</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>Conjunctivitis, Allergic</td>
<td>N/A</td>
<td>2026-01-01</td>
<td>2026-09</td>
<td>60</td>
<td>2025-09-15</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05390528">NCT05390528</a></td>
<td>Shanghai Henlius Biotech</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Advanced Tumors, Lymphoma, Metastatic Tumors</td>
<td>PHASE1, PHASE2</td>
<td>2022-06-20</td>
<td>2024-12-30</td>
<td>30</td>
<td>2023-08-07</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05607563">NCT05607563</a></td>
<td>Biotheus Inc.</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Advanced Tumor</td>
<td>PHASE1</td>
<td>2022-11-21</td>
<td>2023-12</td>
<td>54</td>
<td>2023-02-07</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04818619">NCT04818619</a></td>
<td>Assiut University</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Chronic Myeloid Leukemia</td>
<td>N/A</td>
<td>2021-04</td>
<td>2022-12</td>
<td>65</td>
<td>2021-03-25</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05394168">NCT05394168</a></td>
<td>Shanghai Henlius Biotech</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Advanced/Metastatic Solid Tumors</td>
<td>PHASE1</td>
<td>2022-12-09</td>
<td>2025-03-04</td>
<td>12</td>
<td>2024-03-28</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04995523">NCT04995523</a></td>
<td>AstraZeneca</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Non-Small-Cell Lung Carcinoma</td>
<td>PHASE1, PHASE2</td>
<td>2021-09-14</td>
<td>2028-03-16</td>
<td>210</td>
<td>2025-11-21</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04500678">NCT04500678</a></td>
<td>University of Hawaii</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>HIV/AIDS</td>
<td>PHASE2, PHASE3</td>
<td>2019-02-01</td>
<td>2022-12-31</td>
<td>38</td>
<td>2020-08-04</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05653284">NCT05653284</a></td>
<td>Akeso</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Advanced Malignant Tumors</td>
<td>PHASE1</td>
<td>2023-02-09</td>
<td>2024-05-30</td>
<td>19</td>
<td>2024-08-11</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06250036">NCT06250036</a></td>
<td>Royal Marsden NHS Foundation Trust</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Locally Advanced Gastric Adenocarcinoma, MSI-H/dMMR Gastric Cancer, MSI-H/dMMR Gastroesophageal-junction Cancer</td>
<td>PHASE2</td>
<td>2025-02-20</td>
<td>2031-09-01</td>
<td>50</td>
<td>2025-08-19</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05102214">NCT05102214</a></td>
<td>Shanghai Henlius Biotech</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Locally Advanced or Metastatic Solid Tumors, Non-small Cell Lung Cancer</td>
<td>PHASE1, PHASE2</td>
<td>2022-05-03</td>
<td>2024-02</td>
<td>150</td>
<td>2023-08-07</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05023109">NCT05023109</a></td>
<td>Shanghai Zhongshan Hospital</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Biliary Tract Carcinoma</td>
<td>PHASE2</td>
<td>2021-02-01</td>
<td>2024-12-01</td>
<td>45</td>
<td>2023-08-12</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04656535">NCT04656535</a></td>
<td>Yale University</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Glioblastoma</td>
<td>EARLY_PHASE1</td>
<td>2021-04-21</td>
<td>2026-12-31</td>
<td>46</td>
<td>2026-01-06</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05019677">NCT05019677</a></td>
<td>Fudan University</td>
<td>🟢 No Change</td>
<td>WITHDRAWN</td>
<td>Intrahepatic Cholangiocarcinoma</td>
<td>PHASE2</td>
<td>2021-09-01</td>
<td>2024-12-01</td>
<td>0</td>
<td>2022-03-22</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05537051">NCT05537051</a></td>
<td>Biotheus Inc.</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Advanced Solid Tumours</td>
<td>PHASE1</td>
<td>2023-10-30</td>
<td>2025-12-31</td>
<td>30</td>
<td>2023-02-07</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06349980">NCT06349980</a></td>
<td>Shanghai Henlius Biotech</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Carcinoma, Hepatocellular</td>
<td>PHASE2</td>
<td>2024-08-05</td>
<td>2027-02-10</td>
<td>117</td>
<td>2024-12-15</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05061628">NCT05061628</a></td>
<td>Shanghai Junshi Bioscience Co., Ltd.</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Advanced Tumors</td>
<td>PHASE1</td>
<td>2021-04-21</td>
<td>2024-09-30</td>
<td>176</td>
<td>2021-09-21</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05130177">NCT05130177</a></td>
<td>Diwakar Davar</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Melanoma</td>
<td>PHASE2</td>
<td>2022-03-16</td>
<td>2031-01</td>
<td>26</td>
<td>2025-05-02</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06773507">NCT06773507</a></td>
<td>Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Advanced Esophageal Cancers, Advanced Non-small Cell Lung Cancer (NSCLC)</td>
<td>PHASE1</td>
<td>2025-05-12</td>
<td>2027-06</td>
<td>80</td>
<td>2025-07-07</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05060432">NCT05060432</a></td>
<td>iTeos Belgium SA</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Advanced Cancer, Lung Cancer, Head and Neck Cancer, Melanoma</td>
<td>PHASE1, PHASE2</td>
<td>2021-09-06</td>
<td>2025-07</td>
<td>153</td>
<td>2024-06-19</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05294952">NCT05294952</a></td>
<td>Assiut University</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>Pre-Eclampsia</td>
<td>PHASE4</td>
<td>2025-01-01</td>
<td>2025-11-04</td>
<td>82</td>
<td>2024-02-01</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05706207">NCT05706207</a></td>
<td>Huabo Biopharm Co., Ltd.</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Advanced Solid Tumor</td>
<td>PHASE1</td>
<td>2021-12-21</td>
<td>2023-09-30</td>
<td>36</td>
<td>2023-01-20</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05253105">NCT05253105</a></td>
<td>Shanghai Junshi Bioscience Co., Ltd.</td>
<td>🟢 No Change</td>
<td>WITHDRAWN</td>
<td>Previously Treated, Advanced, Malignancies</td>
<td>PHASE1</td>
<td>2022-03-15</td>
<td>2027-01</td>
<td>0</td>
<td>2022-05-24</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05394337">NCT05394337</a></td>
<td>M.D.&nbsp;Anderson Cancer Center</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Metastatic Malignancy</td>
<td>PHASE1, PHASE2</td>
<td>2023-02-23</td>
<td>2025-12-31</td>
<td>10</td>
<td>2025-10-07</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06754501">NCT06754501</a></td>
<td>M.D.&nbsp;Anderson Cancer Center</td>
<td>🔴 Changed</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Cancer</td>
<td>PHASE2</td>
<td>2025-04-11</td>
<td>2029-07-01</td>
<td>4</td>
<td>2026-02-16</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04270942">NCT04270942</a></td>
<td>Provention Bio, a Sanofi Company</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Diabetes Mellitus, Type 1</td>
<td>PHASE2</td>
<td>2020-02-26</td>
<td>2024-01-22</td>
<td>6</td>
<td>2025-01-20</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06713798">NCT06713798</a></td>
<td>Gustave Roussy, Cancer Campus, Grand Paris</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>Metastatic Cancer Lung, Advanced Lung Cancer, CBNPC Cancer</td>
<td>PHASE2</td>
<td>2025-07</td>
<td>2030-01</td>
<td>115</td>
<td>2025-06-23</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04047862">NCT04047862</a></td>
<td>BeiGene</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Locally Advanced and Metastatic Solid Tumors</td>
<td>PHASE1</td>
<td>2019-08-15</td>
<td>2024-08-07</td>
<td>446</td>
<td>2025-08-04</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05757492">NCT05757492</a></td>
<td>Coherus Oncology, Inc.</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Advanced Solid Tumor, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma</td>
<td>PHASE1</td>
<td>2023-04-26</td>
<td>2024-07-31</td>
<td>22</td>
<td>2025-04-30</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04952597">NCT04952597</a></td>
<td>BeiGene</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Limited Stage Small Cell Lung Cancer</td>
<td>PHASE2</td>
<td>2021-07-15</td>
<td>2023-07-26</td>
<td>126</td>
<td>2024-10-23</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04933227">NCT04933227</a></td>
<td>Hoffmann-La Roche</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Stomach Neoplasms, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma</td>
<td>PHASE2</td>
<td>2021-08-06</td>
<td>2023-11-17</td>
<td>29</td>
<td>2024-11-11</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05805501">NCT05805501</a></td>
<td>Hoffmann-La Roche</td>
<td>🔴 Changed</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Renal Cell Carcinoma</td>
<td>PHASE2</td>
<td>2023-04-21</td>
<td>2026-10-31</td>
<td>199</td>
<td>2026-02-10</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT07337447">NCT07337447</a></td>
<td>Hospices Civils de Lyon</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>Carcinoma, Neuroendocrine</td>
<td>PHASE2</td>
<td>2026-04</td>
<td>2030-04</td>
<td>122</td>
<td>2026-01-07</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04672356">NCT04672356</a></td>
<td>Innovent Biologics (Suzhou) Co.&nbsp;Ltd.</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Advanced Lung Cancer</td>
<td>PHASE1</td>
<td>2021-01-25</td>
<td>2023-06-01</td>
<td>19</td>
<td>2023-06-18</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04354246">NCT04354246</a></td>
<td>Compugen Ltd</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Advanced Cancer, Ovarian Cancer, Lung Cancer, Colon Cancer, Plasma Cell Neoplasm, Multiple Myeloma, HNSCC, Microsatellite Stable Colorectal Carcinoma, MSS-CRC</td>
<td>PHASE1</td>
<td>2020-03-31</td>
<td>2025-12-30</td>
<td>110</td>
<td>2025-05-18</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05414032">NCT05414032</a></td>
<td>University Health Network, Toronto</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)</td>
<td>PHASE2</td>
<td>2023-07-12</td>
<td>2026-07</td>
<td>200</td>
<td>2025-03-25</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04353830">NCT04353830</a></td>
<td>Innovent Biologics (Suzhou) Co.&nbsp;Ltd.</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Advanced Malignancies</td>
<td>PHASE1</td>
<td>2020-05-22</td>
<td>2022-05-11</td>
<td>34</td>
<td>2023-02-28</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04672369">NCT04672369</a></td>
<td>Innovent Biologics (Suzhou) Co.&nbsp;Ltd.</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Advanced Lung Cancer</td>
<td>PHASE1</td>
<td>2021-06-06</td>
<td>2023-06-01</td>
<td>42</td>
<td>2023-06-18</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05009069">NCT05009069</a></td>
<td>Hoffmann-La Roche</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Rectal Neoplasms, Rectal Cancer</td>
<td>PHASE2</td>
<td>2022-03-18</td>
<td>2026-11-06</td>
<td>58</td>
<td>2026-01-16</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT03447678">NCT03447678</a></td>
<td>Fondazione IRCCS Istituto Nazionale dei Tumori, Milano</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Non Small Cell Lung Cancer (NSCLC)</td>
<td>PHASE2</td>
<td>2018-05-23</td>
<td>2022-05-31</td>
<td>65</td>
<td>2021-06-08</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05568095">NCT05568095</a></td>
<td>Arcus Biosciences, Inc.</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Advanced Upper Gastrointestinal Tract Adenocarcinoma</td>
<td>PHASE3</td>
<td>2022-11-21</td>
<td>2026-06</td>
<td>1040</td>
<td>2026-01-30</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06003621">NCT06003621</a></td>
<td>Omico</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Solid Tumor, Adult</td>
<td>PHASE2</td>
<td>2023-12-15</td>
<td>2028-11-01</td>
<td>96</td>
<td>2024-11-13</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06773481">NCT06773481</a></td>
<td>Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Glioma, Glioma Tumor Recurrence, Glioma, Recurrent High Grade, Glioblastomas (GBM), Glioblastoma WHO Grade IV</td>
<td>PHASE1</td>
<td>2025-04-07</td>
<td>2026-12</td>
<td>40</td>
<td>2025-07-07</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06777628">NCT06777628</a></td>
<td>IRCCS Azienda Ospedaliero-Universitaria di Bologna</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Liver Cancer, Adult</td>
<td>N/A</td>
<td>2024-09-15</td>
<td>2028-10-15</td>
<td>100</td>
<td>2025-01-14</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT03708224">NCT03708224</a></td>
<td>Alain Algazi</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Cancer, Carcinoma, Squamous Cell Carcinoma, Head and Neck Cancer</td>
<td>PHASE2</td>
<td>2019-03-08</td>
<td>2028-06-30</td>
<td>55</td>
<td>2025-01-24</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05120375">NCT05120375</a></td>
<td>Bio-Thera Solutions</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Solid Tumor</td>
<td>PHASE1</td>
<td>2022-02-17</td>
<td>2023-04-07</td>
<td>5</td>
<td>2023-10-08</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT03652402">NCT03652402</a></td>
<td>Assistance Publique - Hôpitaux de Paris</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Kidney Transplant Rejection, Kidney Transplantation, Risk Stratification, Prognosis</td>
<td>N/A</td>
<td>2018-11-27</td>
<td>2021-10-28</td>
<td>558</td>
<td>2024-06-04</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04570839">NCT04570839</a></td>
<td>Compugen Ltd</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Endometrial Neoplasms, Ovarian Cancer, Solid Tumor, Head and Neck Cancer</td>
<td>PHASE1, PHASE2</td>
<td>2020-08-31</td>
<td>2024-05-15</td>
<td>48</td>
<td>2024-07-17</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05417321">NCT05417321</a></td>
<td>Shanghai Huaota Biopharmaceutical Co., Ltd.</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Advanced Solid Tumor, NSCLC</td>
<td>PHASE1, PHASE2</td>
<td>2022-08-25</td>
<td>2025-08-01</td>
<td>80</td>
<td>2025-01-02</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05520294">NCT05520294</a></td>
<td>University of Colorado, Denver</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Melanoma</td>
<td>N/A</td>
<td>2022-09-01</td>
<td>2024-08-31</td>
<td>90</td>
<td>2024-04-15</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT03486119">NCT03486119</a></td>
<td>Yonsei University</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Non -Small Cell Lung Cancer</td>
<td>N/A</td>
<td>2018-02-05</td>
<td>2020-07-07</td>
<td>60</td>
<td>2020-10-14</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05327530">NCT05327530</a></td>
<td>EMD Serono Research &amp; Development Institute, Inc.</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Locally Advanced or Metastatic Urothelial Carcinoma</td>
<td>PHASE2</td>
<td>2022-08-17</td>
<td>2026-06-25</td>
<td>256</td>
<td>2026-01-23</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04262856">NCT04262856</a></td>
<td>Arcus Biosciences, Inc.</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer, Squamous Non Small Cell Lung Cancer, Lung Cancer</td>
<td>PHASE2</td>
<td>2020-05-28</td>
<td>2025-07-09</td>
<td>151</td>
<td>2025-08-25</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04465643">NCT04465643</a></td>
<td>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Nerve Sheath Tumors</td>
<td>PHASE1</td>
<td>2021-06-08</td>
<td>2025-07-30</td>
<td>13</td>
<td>2025-10-02</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06328036">NCT06328036</a></td>
<td>National Cancer Institute (NCI)</td>
<td>🟢 No Change</td>
<td>WITHDRAWN</td>
<td>Recurrent Glioblastoma, IDH-Wildtype</td>
<td>PHASE2</td>
<td>2025-04-30</td>
<td>2025-07-01</td>
<td>0</td>
<td>2024-12-27</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04736173">NCT04736173</a></td>
<td>Arcus Biosciences, Inc.</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer, Squamous Non Small Cell Lung Cancer, Lung Cancer</td>
<td>PHASE2</td>
<td>2021-02-08</td>
<td>2027-05</td>
<td>169</td>
<td>2025-12-09</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05289492">NCT05289492</a></td>
<td>iTeos Therapeutics</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Multiple Myeloma</td>
<td>PHASE1</td>
<td>2022-05-01</td>
<td>2023-11-29</td>
<td>16</td>
<td>2024-10-23</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05126537">NCT05126537</a></td>
<td>Southeast University, China</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>28 Day Mortality</td>
<td>N/A</td>
<td>2022-01-01</td>
<td>2022-12-31</td>
<td>100</td>
<td>2022-11-25</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT07376512">NCT07376512</a></td>
<td>Centre Georges Francois Leclerc</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>Non-Small Cell Lung Cancer, Melanoma (Skin Cancer)</td>
<td>N/A</td>
<td>2026-03-01</td>
<td>2030-03-01</td>
<td>378</td>
<td>2026-01-22</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05743504">NCT05743504</a></td>
<td>National Taiwan University Hospital</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Locally Advanced Esophageal Squamous Cell Carcinoma</td>
<td>PHASE1, PHASE2</td>
<td>2023-09-18</td>
<td>2025-11-30</td>
<td>32</td>
<td>2024-01-31</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05073484">NCT05073484</a></td>
<td>Bio-Thera Solutions</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Advanced Solid Tumor</td>
<td>PHASE1</td>
<td>2021-10-29</td>
<td>2023-03-30</td>
<td>13</td>
<td>2023-10-09</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT07115043">NCT07115043</a></td>
<td>AstraZeneca</td>
<td>🔴 Changed</td>
<td>RECRUITING</td>
<td>Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin), Renal Cell Carcinoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma, Gastric Cancer/Gastroesophageal Junction Cancer, High Grade Serous Ovarian Carcinoma</td>
<td>PHASE1, PHASE2</td>
<td>2025-07-29</td>
<td>2029-10-02</td>
<td>60</td>
<td>2026-02-04</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04791839">NCT04791839</a></td>
<td>Washington University School of Medicine</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Non Small Cell Lung Cancer, Non-small Cell Carcinoma, Non-small Cell Lung Cancer</td>
<td>PHASE2</td>
<td>2021-08-04</td>
<td>2030-06-30</td>
<td>30</td>
<td>2025-11-04</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05020912">NCT05020912</a></td>
<td>Case Comprehensive Cancer Center</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Basal Cell Carcinoma</td>
<td>PHASE2</td>
<td>2021-12-13</td>
<td>2027-12</td>
<td>28</td>
<td>2025-11-25</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06334406">NCT06334406</a></td>
<td>Centre Hospitalier Universitaire de Besancon</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>Bladder Cancer</td>
<td>N/A</td>
<td>2024-04-02</td>
<td>2026-04-02</td>
<td>33</td>
<td>2024-03-19</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05904886">NCT05904886</a></td>
<td>Hoffmann-La Roche</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Hepatocellular Carcinoma</td>
<td>PHASE3</td>
<td>2023-09-14</td>
<td>2026-09-01</td>
<td>687</td>
<td>2025-12-30</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT03342417">NCT03342417</a></td>
<td>ExcellaBio LLC</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Breast Cancer Female, Ovarian Cancer, Gastric Cancer</td>
<td>PHASE2</td>
<td>2018-02-14</td>
<td>2019-05-29</td>
<td>5</td>
<td>2021-11-05</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT03739710">NCT03739710</a></td>
<td>GlaxoSmithKline</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Neoplasms</td>
<td>PHASE2</td>
<td>2019-01-24</td>
<td>2024-05-02</td>
<td>175</td>
<td>2025-06-13</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT07343310">NCT07343310</a></td>
<td>Kine Sciences Co., Ltd.</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>CIDP - Chronic Inflammatory Demyelinating Polyneuropathy</td>
<td>PHASE1</td>
<td>2024-08-27</td>
<td>2025-04-14</td>
<td>9</td>
<td>2026-01-15</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04682665">NCT04682665</a></td>
<td>University of Leeds</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Colon Cancer Liver Metastasis</td>
<td>N/A</td>
<td>2021-09-16</td>
<td>2024-07-31</td>
<td>81</td>
<td>2024-12-03</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05123482">NCT05123482</a></td>
<td>AstraZeneca</td>
<td>🔴 Changed</td>
<td>RECRUITING</td>
<td>Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer, Endometrial Cancer, Squamous Non-Small Cell Lung Cancer</td>
<td>PHASE1, PHASE2</td>
<td>2021-10-18</td>
<td>2027-09-29</td>
<td>460</td>
<td>2026-02-11</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT07161414">NCT07161414</a></td>
<td>AstraZeneca</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Advanced Solid Tumors</td>
<td>PHASE1</td>
<td>2025-11-25</td>
<td>2029-07-24</td>
<td>40</td>
<td>2025-12-18</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT07213882">NCT07213882</a></td>
<td>Assistance Publique - Hôpitaux de Paris</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>Cutaneous T Cell Lymphoma (CTCL), Mycosis Fungoides, Sezary Syndrome</td>
<td>EARLY_PHASE1</td>
<td>2026-01-01</td>
<td>2028-08-01</td>
<td>30</td>
<td>2025-10-02</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT07015164">NCT07015164</a></td>
<td>Assistance Publique - Hôpitaux de Paris</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>HIV</td>
<td>N/A</td>
<td>2025-06-10</td>
<td>2026-09-11</td>
<td>80</td>
<td>2025-06-03</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05702229">NCT05702229</a></td>
<td>AstraZeneca</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Gastric Cancer</td>
<td>PHASE2</td>
<td>2023-01-16</td>
<td>2027-09-28</td>
<td>240</td>
<td>2025-11-14</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04836507">NCT04836507</a></td>
<td>Curocell Inc.</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal Large B-Cell Lymphoma (PMBCL), High-grade B-cell Lymphoma, Transformed Follicular Lymphoma (TFL)</td>
<td>PHASE1, PHASE2</td>
<td>2021-03-02</td>
<td>2028-02</td>
<td>91</td>
<td>2021-04-29</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05633927">NCT05633927</a></td>
<td>Hospitales Universitarios Virgen del Rocío</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>SARS-CoV-2 RNA Vaccines, HIV Infection</td>
<td>N/A</td>
<td>2021-04-01</td>
<td>2022-12-01</td>
<td>48</td>
<td>2024-10-09</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06897436">NCT06897436</a></td>
<td>Medical University of Lublin</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>Endometriosis</td>
<td>N/A</td>
<td>2025-05-01</td>
<td>2029-12-31</td>
<td>60</td>
<td>2025-03-24</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT03628677">NCT03628677</a></td>
<td>Arcus Biosciences, Inc.</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Solid Tumor, Unspecified, Adult</td>
<td>PHASE1</td>
<td>2018-09-12</td>
<td>2025-01-23</td>
<td>75</td>
<td>2025-02-03</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05775159">NCT05775159</a></td>
<td>AstraZeneca</td>
<td>🔴 Changed</td>
<td>RECRUITING</td>
<td>Hepatocellular Carcinoma, Biliary Tract Cancer</td>
<td>PHASE2</td>
<td>2023-04-24</td>
<td>2027-10-28</td>
<td>294</td>
<td>2026-02-16</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04624828">NCT04624828</a></td>
<td>Istituto Clinico Humanitas</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Oligorecurrent and Oligoprogressive Prostate Cancer Patients</td>
<td>NA</td>
<td>2020-10-19</td>
<td>2026-07</td>
<td>40</td>
<td>2025-04-22</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06338657">NCT06338657</a></td>
<td>University of Southern California</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Head and Neck Squamous Cell Carcinoma</td>
<td>PHASE1</td>
<td>2024-04-01</td>
<td>2025-09-09</td>
<td>1</td>
<td>2025-09-09</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06860815">NCT06860815</a></td>
<td>City of Hope Medical Center</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver</td>
<td>PHASE2</td>
<td>2026-04-01</td>
<td>2027-01-30</td>
<td>11</td>
<td>2026-01-27</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05574335">NCT05574335</a></td>
<td>National Institute of Allergy and Infectious Diseases (NIAID)</td>
<td>🔴 Changed</td>
<td>TERMINATED</td>
<td>Type 1 Diabetes Mellitus</td>
<td>PHASE1, PHASE2</td>
<td>2023-04-26</td>
<td>2025-10-20</td>
<td>8</td>
<td>2026-02-10</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06302556">NCT06302556</a></td>
<td>Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>Lung Transplant Rejection</td>
<td>N/A</td>
<td>2024-04</td>
<td>2026-02</td>
<td>280</td>
<td>2024-03-06</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04761198">NCT04761198</a></td>
<td>Mereo BioPharma</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Solid Tumor, Adult, Advanced Solid Tumor, Metastatic Solid Tumor</td>
<td>PHASE1, PHASE2</td>
<td>2021-03-23</td>
<td>2023-10-30</td>
<td>76</td>
<td>2025-03-07</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT07324642">NCT07324642</a></td>
<td>Kine Sciences Co., Ltd.</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Healthy Volunteers</td>
<td>PHASE1</td>
<td>2025-05-26</td>
<td>2025-08-25</td>
<td>24</td>
<td>2025-12-24</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT03563716">NCT03563716</a></td>
<td>Genentech, Inc.</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Non-small Cell Lung Cancer</td>
<td>PHASE2</td>
<td>2018-08-10</td>
<td>2025-11-24</td>
<td>135</td>
<td>2025-12-30</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05809895">NCT05809895</a></td>
<td>Novartis Pharmaceuticals</td>
<td>🟢 No Change</td>
<td>WITHDRAWN</td>
<td>Triple Negative Breast Cancer</td>
<td>PHASE2</td>
<td>2023-09-15</td>
<td>2029-07-18</td>
<td>0</td>
<td>2023-07-21</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04457778">NCT04457778</a></td>
<td>EMD Serono Research &amp; Development Institute, Inc.</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Metastatic Solid Tumors</td>
<td>PHASE1</td>
<td>2020-07-10</td>
<td>2023-06-23</td>
<td>58</td>
<td>2023-12-07</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT03772899">NCT03772899</a></td>
<td>London Health Sciences Centre Research Institute OR Lawson Research Institute of St.&nbsp;Joseph’s</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Melanoma</td>
<td>PHASE1</td>
<td>2019-03-27</td>
<td>2026-08</td>
<td>20</td>
<td>2025-03-26</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05645692">NCT05645692</a></td>
<td>Hoffmann-La Roche</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Urothelial Cancer</td>
<td>PHASE2</td>
<td>2023-04-13</td>
<td>2026-12-31</td>
<td>204</td>
<td>2026-01-28</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04693234">NCT04693234</a></td>
<td>BeiGene</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Cervical Cancer</td>
<td>PHASE2</td>
<td>2021-02-15</td>
<td>2023-08-31</td>
<td>178</td>
<td>2025-04-09</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06346197">NCT06346197</a></td>
<td>Centre Leon Berard</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Gastric Cancer, MSI-H, Metastatic Cancer, Advanced Cancer</td>
<td>PHASE3</td>
<td>2025-12-08</td>
<td>2028-05-15</td>
<td>132</td>
<td>2025-12-19</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05780073">NCT05780073</a></td>
<td>Fundació Institut Germans Trias i Pujol</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>HIV Infection Primary</td>
<td>PHASE2</td>
<td>2023-10-16</td>
<td>2025-04-01</td>
<td>60</td>
<td>2025-09-16</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04732494">NCT04732494</a></td>
<td>BeiGene</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Esophageal Squamous Cell Carcinoma</td>
<td>PHASE2</td>
<td>2021-03-31</td>
<td>2023-12-26</td>
<td>125</td>
<td>2024-12-23</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04374877">NCT04374877</a></td>
<td>Coherus Oncology, Inc.</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma, Non-small Cell Lung Cancer</td>
<td>PHASE1</td>
<td>2020-04-22</td>
<td>2025-06-05</td>
<td>145</td>
<td>2025-11-06</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT03667716">NCT03667716</a></td>
<td>Compugen Ltd</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Advanced Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer, Endometrial Cancer, Ovarian Neoplasm, Triple Negative Breast Cancer, Lung Neoplasm, Neoplasm Malignant, Colo-rectal Cancer</td>
<td>PHASE1</td>
<td>2018-09-06</td>
<td>2024-01-30</td>
<td>121</td>
<td>2025-01-15</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04746924">NCT04746924</a></td>
<td>BeiGene</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Non-small Cell Lung Cancer, NSCLC</td>
<td>PHASE3</td>
<td>2021-06-08</td>
<td>2026-03-31</td>
<td>662</td>
<td>2025-06-23</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06784947">NCT06784947</a></td>
<td>University of Colorado, Denver</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Microsatellite Stable (MSS) Colorectal Cancer (CRC), Metastatic Colorectal Cancer (CRC), Colorectal Cancer Stage IV</td>
<td>PHASE2</td>
<td>2025-03-25</td>
<td>2028-05</td>
<td>13</td>
<td>2025-10-01</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT07098338">NCT07098338</a></td>
<td>AstraZeneca</td>
<td>🔴 Changed</td>
<td>RECRUITING</td>
<td>Non-Small Cell Lung Cancer</td>
<td>PHASE2</td>
<td>2025-08-07</td>
<td>2029-04-06</td>
<td>278</td>
<td>2026-02-03</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT07307053">NCT07307053</a></td>
<td>Cancer Institute and Hospital, Chinese Academy of Medical Sciences</td>
<td>🟢 No Change</td>
<td>NOT_YET_RECRUITING</td>
<td>Rare Malignant Neoplasm, Advanced Solid Tumors, Metastatic Solid Tumors</td>
<td>PHASE1, PHASE2</td>
<td>2026-01-01</td>
<td>2031-01-31</td>
<td>600</td>
<td>2025-12-13</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06864598">NCT06864598</a></td>
<td>Peking University People’s Hospital</td>
<td>🟢 No Change</td>
<td>ENROLLING_BY_INVITATION</td>
<td>Graft-versus-host Disease (GVHD)</td>
<td>N/A</td>
<td>2025-01-09</td>
<td>2026-10-31</td>
<td>100</td>
<td>2025-03-04</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06532539">NCT06532539</a></td>
<td>Shandong Cancer Hospital and Institute</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Endometrial Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis</td>
<td>PHASE2</td>
<td>2024-06-13</td>
<td>2026-05</td>
<td>30</td>
<td>2024-07-29</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05014815">NCT05014815</a></td>
<td>BeiGene</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC), Nonsmall Cell Lung Cancer, Stage IIIB, Nonsmall Cell Lung Cancer, Stage IV</td>
<td>PHASE2</td>
<td>2021-11-16</td>
<td>2024-09-04</td>
<td>272</td>
<td>2025-08-28</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT03661047">NCT03661047</a></td>
<td>Massachusetts General Hospital</td>
<td>🟢 No Change</td>
<td>WITHDRAWN</td>
<td>Colon Cancer</td>
<td>PHASE2</td>
<td>2019-11-30</td>
<td>2021-11-30</td>
<td>0</td>
<td>2021-11-10</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05127824">NCT05127824</a></td>
<td>Jodi Maranchie</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Carcinoma, Renal Cell</td>
<td>PHASE2</td>
<td>2023-07-06</td>
<td>2026-12</td>
<td>42</td>
<td>2025-04-30</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04866017">NCT04866017</a></td>
<td>BeiGene</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Non Small Cell Lung Cancer</td>
<td>PHASE3</td>
<td>2021-06-17</td>
<td>2023-10-17</td>
<td>63</td>
<td>2024-10-09</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04303169">NCT04303169</a></td>
<td>Merck Sharp &amp; Dohme LLC</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Melanoma</td>
<td>PHASE1, PHASE2</td>
<td>2020-06-26</td>
<td>2025-09-24</td>
<td>146</td>
<td>2025-10-23</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05329766">NCT05329766</a></td>
<td>Arcus Biosciences, Inc.</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Gastrointestinal Tract Malignancies</td>
<td>PHASE2</td>
<td>2022-06-10</td>
<td>2027-06</td>
<td>332</td>
<td>2026-01-27</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT07221253">NCT07221253</a></td>
<td>AstraZeneca</td>
<td>🔴 Changed</td>
<td>RECRUITING</td>
<td>Biliary Tract Cancer</td>
<td>PHASE3</td>
<td>2025-12-04</td>
<td>2029-07-04</td>
<td>1100</td>
<td>2026-02-09</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04323202">NCT04323202</a></td>
<td>Case Comprehensive Cancer Center</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Basal Cell Carcinoma of the Head and Neck</td>
<td>PHASE1</td>
<td>2020-08-04</td>
<td>2025-06-25</td>
<td>13</td>
<td>2025-10-23</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04305041">NCT04305041</a></td>
<td>Merck Sharp &amp; Dohme LLC</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Melanoma</td>
<td>PHASE1, PHASE2</td>
<td>2020-06-26</td>
<td>2025-08-25</td>
<td>100</td>
<td>2025-08-28</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT05676931">NCT05676931</a></td>
<td>Gilead Sciences</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Advanced Non-Small Cell Lung Cancer</td>
<td>PHASE2</td>
<td>2023-02-21</td>
<td>2027-12</td>
<td>400</td>
<td>2025-09-29</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06790706">NCT06790706</a></td>
<td>Hospices Civils de Lyon</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Peritoneal Mesothelioma, Gestational Trophoblastic Tumor, Thymoma and Thymic Carcinoma, Anaplastic Thyroid Carcinomas, Gastroenteropancreatic Neuroendocrine Tumor, Carcinoid Tumor</td>
<td>PHASE2</td>
<td>2025-10-01</td>
<td>2031-06</td>
<td>154</td>
<td>2025-10-01</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06996782">NCT06996782</a></td>
<td>AstraZeneca</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Advanced or Metastatic Non-small Cell Lung Cancer</td>
<td>PHASE1, PHASE2</td>
<td>2025-11-24</td>
<td>2029-02-23</td>
<td>152</td>
<td>2026-01-13</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04543617">NCT04543617</a></td>
<td>Hoffmann-La Roche</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Esophageal Squamous Cell Carcinoma</td>
<td>PHASE3</td>
<td>2020-09-28</td>
<td>2027-03-31</td>
<td>760</td>
<td>2026-01-16</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04774484">NCT04774484</a></td>
<td>Francesc Marti</td>
<td>🟢 No Change</td>
<td>WITHDRAWN</td>
<td>End Stage Renal Disease</td>
<td>NA</td>
<td>2023-01</td>
<td>2026-06-30</td>
<td>0</td>
<td>2023-02-10</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05816460">NCT05816460</a></td>
<td>University College Dublin</td>
<td>🟢 No Change</td>
<td>UNKNOWN</td>
<td>Insomnia, Cancer</td>
<td>NA</td>
<td>2023-05-22</td>
<td>2024-06-10</td>
<td>308</td>
<td>2023-05-19</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06868277">NCT06868277</a></td>
<td>AstraZeneca</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Carcinoma, Non-Small Cell Lung</td>
<td>PHASE3</td>
<td>2025-04-10</td>
<td>2030-12-02</td>
<td>830</td>
<td>2026-01-12</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT05665595">NCT05665595</a></td>
<td>Merck Sharp &amp; Dohme LLC</td>
<td>🔴 Changed</td>
<td>COMPLETED</td>
<td>Melanoma</td>
<td>PHASE3</td>
<td>2023-01-19</td>
<td>2025-09-26</td>
<td>1594</td>
<td>2025-10-03</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04305054">NCT04305054</a></td>
<td>Merck Sharp &amp; Dohme LLC</td>
<td>🟢 No Change</td>
<td>ACTIVE_NOT_RECRUITING</td>
<td>Melanoma</td>
<td>PHASE1, PHASE2</td>
<td>2020-07-01</td>
<td>2026-04-20</td>
<td>315</td>
<td>2025-08-28</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT04256421">NCT04256421</a></td>
<td>Hoffmann-La Roche</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Small Cell Lung Cancer</td>
<td>PHASE3</td>
<td>2020-02-04</td>
<td>2025-07-31</td>
<td>490</td>
<td>2026-01-09</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04294810">NCT04294810</a></td>
<td>Hoffmann-La Roche</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Non-Small Cell Lung Cancer</td>
<td>PHASE3</td>
<td>2020-03-04</td>
<td>2025-12-30</td>
<td>620</td>
<td>2026-01-29</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT03198546">NCT03198546</a></td>
<td>Second Affiliated Hospital of Guangzhou Medical University</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Hepatocellular Carcinoma, Immunotherapy, CAR, GPC3 Gene Inactivation, T Cell, Squamous Cell Lung Cancer</td>
<td>PHASE1</td>
<td>2017-07-01</td>
<td>2036-08-01</td>
<td>30</td>
<td>2024-06-22</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06692738">NCT06692738</a></td>
<td>AstraZeneca</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Non-small Cell Lung Cancer</td>
<td>PHASE3</td>
<td>2024-11-18</td>
<td>2029-10-08</td>
<td>880</td>
<td>2026-01-20</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT03198052">NCT03198052</a></td>
<td>Second Affiliated Hospital of Guangzhou Medical University</td>
<td>🟢 No Change</td>
<td>RECRUITING</td>
<td>Lung Cancer, Cancer, Immunotherapy, CAR-T Cell</td>
<td>PHASE1</td>
<td>2017-07-01</td>
<td>2036-08-01</td>
<td>30</td>
<td>2024-06-22</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT06989112">NCT06989112</a></td>
<td>AstraZeneca</td>
<td>🔴 Changed</td>
<td>RECRUITING</td>
<td>Endometrial Cancer</td>
<td>PHASE3</td>
<td>2025-03-27</td>
<td>2031-02-19</td>
<td>600</td>
<td>2026-02-09</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT06627647">NCT06627647</a></td>
<td>AstraZeneca</td>
<td>🔴 Changed</td>
<td>RECRUITING</td>
<td>Non-squamous Non-small Cell Lung Cancer</td>
<td>PHASE3</td>
<td>2024-11-27</td>
<td>2030-03-25</td>
<td>878</td>
<td>2026-02-11</td>
</tr>
<tr class="even">
<td><a href="https://clinicaltrials.gov/study/NCT04585815">NCT04585815</a></td>
<td>Pfizer</td>
<td>🟢 No Change</td>
<td>TERMINATED</td>
<td>Carcinoma, Non-Small-Cell Lung</td>
<td>PHASE1, PHASE2</td>
<td>2020-11-10</td>
<td>2024-10-29</td>
<td>34</td>
<td>2025-12-18</td>
</tr>
<tr class="odd">
<td><a href="https://clinicaltrials.gov/study/NCT02443155">NCT02443155</a></td>
<td>Novo Nordisk A/S</td>
<td>🟢 No Change</td>
<td>COMPLETED</td>
<td>Diabetes, Diabetes Mellitus, Type 1</td>
<td>PHASE2</td>
<td>2015-11-10</td>
<td>2019-02-27</td>
<td>308</td>
<td>2021-03-10</td>
</tr>
</tbody>
</table>


</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
  window.document.addEventListener("DOMContentLoaded", function (event) {
    const icon = "";
    const anchorJS = new window.AnchorJS();
    anchorJS.options = {
      placement: 'right',
      icon: icon
    };
    anchorJS.add('.anchored');
    const isCodeAnnotation = (el) => {
      for (const clz of el.classList) {
        if (clz.startsWith('code-annotation-')) {                     
          return true;
        }
      }
      return false;
    }
    const onCopySuccess = function(e) {
      // button target
      const button = e.trigger;
      // don't keep focus
      button.blur();
      // flash "checked"
      button.classList.add('code-copy-button-checked');
      var currentTitle = button.getAttribute("title");
      button.setAttribute("title", "Copied!");
      let tooltip;
      if (window.bootstrap) {
        button.setAttribute("data-bs-toggle", "tooltip");
        button.setAttribute("data-bs-placement", "left");
        button.setAttribute("data-bs-title", "Copied!");
        tooltip = new bootstrap.Tooltip(button, 
          { trigger: "manual", 
            customClass: "code-copy-button-tooltip",
            offset: [0, -8]});
        tooltip.show();    
      }
      setTimeout(function() {
        if (tooltip) {
          tooltip.hide();
          button.removeAttribute("data-bs-title");
          button.removeAttribute("data-bs-toggle");
          button.removeAttribute("data-bs-placement");
        }
        button.setAttribute("title", currentTitle);
        button.classList.remove('code-copy-button-checked');
      }, 1000);
      // clear code selection
      e.clearSelection();
    }
    const getTextToCopy = function(trigger) {
      const outerScaffold = trigger.parentElement.cloneNode(true);
      const codeEl = outerScaffold.querySelector('code');
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
    const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
      text: getTextToCopy
    });
    clipboard.on('success', onCopySuccess);
    if (window.document.getElementById('quarto-embedded-source-code-modal')) {
      const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
        text: getTextToCopy,
        container: window.document.getElementById('quarto-embedded-source-code-modal')
      });
      clipboardModal.on('success', onCopySuccess);
    }
      var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
      var mailtoRegex = new RegExp(/^mailto:/);
        var filterRegex = new RegExp("https:\/\/partrita\.github\.io\/clinicaltrial-watch\/");
      var isInternal = (href) => {
          return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
      }
      // Inspect non-navigation links and adorn them if external
     var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
      for (var i=0; i<links.length; i++) {
        const link = links[i];
        if (!isInternal(link.href)) {
          // undo the damage that might have been done by quarto-nav.js in the case of
          // links that we want to consider external
          if (link.dataset.originalHref !== undefined) {
            link.href = link.dataset.originalHref;
          }
        }
      }
    function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
      const config = {
        allowHTML: true,
        maxWidth: 500,
        delay: 100,
        arrow: false,
        appendTo: function(el) {
            return el.parentElement;
        },
        interactive: true,
        interactiveBorder: 10,
        theme: 'quarto',
        placement: 'bottom-start',
      };
      if (contentFn) {
        config.content = contentFn;
      }
      if (onTriggerFn) {
        config.onTrigger = onTriggerFn;
      }
      if (onUntriggerFn) {
        config.onUntrigger = onUntriggerFn;
      }
      window.tippy(el, config); 
    }
    const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
    for (var i=0; i<noterefs.length; i++) {
      const ref = noterefs[i];
      tippyHover(ref, function() {
        // use id or data attribute instead here
        let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
        try { href = new URL(href).hash; } catch {}
        const id = href.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note) {
          return note.innerHTML;
        } else {
          return "";
        }
      });
    }
    const xrefs = window.document.querySelectorAll('a.quarto-xref');
    const processXRef = (id, note) => {
      // Strip column container classes
      const stripColumnClz = (el) => {
        el.classList.remove("page-full", "page-columns");
        if (el.children) {
          for (const child of el.children) {
            stripColumnClz(child);
          }
        }
      }
      stripColumnClz(note)
      if (id === null || id.startsWith('sec-')) {
        // Special case sections, only their first couple elements
        const container = document.createElement("div");
        if (note.children && note.children.length > 2) {
          container.appendChild(note.children[0].cloneNode(true));
          for (let i = 1; i < note.children.length; i++) {
            const child = note.children[i];
            if (child.tagName === "P" && child.innerText === "") {
              continue;
            } else {
              container.appendChild(child.cloneNode(true));
              break;
            }
          }
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(container);
          }
          return container.innerHTML
        } else {
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(note);
          }
          return note.innerHTML;
        }
      } else {
        // Remove any anchor links if they are present
        const anchorLink = note.querySelector('a.anchorjs-link');
        if (anchorLink) {
          anchorLink.remove();
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        if (note.classList.contains("callout")) {
          return note.outerHTML;
        } else {
          return note.innerHTML;
        }
      }
    }
    for (var i=0; i<xrefs.length; i++) {
      const xref = xrefs[i];
      tippyHover(xref, undefined, function(instance) {
        instance.disable();
        let url = xref.getAttribute('href');
        let hash = undefined; 
        if (url.startsWith('#')) {
          hash = url;
        } else {
          try { hash = new URL(url).hash; } catch {}
        }
        if (hash) {
          const id = hash.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note !== null) {
            try {
              const html = processXRef(id, note.cloneNode(true));
              instance.setContent(html);
            } finally {
              instance.enable();
              instance.show();
            }
          } else {
            // See if we can fetch this
            fetch(url.split('#')[0])
            .then(res => res.text())
            .then(html => {
              const parser = new DOMParser();
              const htmlDoc = parser.parseFromString(html, "text/html");
              const note = htmlDoc.getElementById(id);
              if (note !== null) {
                const html = processXRef(id, note);
                instance.setContent(html);
              } 
            }).finally(() => {
              instance.enable();
              instance.show();
            });
          }
        } else {
          // See if we can fetch a full url (with no hash to target)
          // This is a special case and we should probably do some content thinning / targeting
          fetch(url)
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.querySelector('main.content');
            if (note !== null) {
              // This should only happen for chapter cross references
              // (since there is no id in the URL)
              // remove the first header
              if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
                note.children[0].remove();
              }
              const html = processXRef(null, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      }, function(instance) {
      });
    }
        let selectedAnnoteEl;
        const selectorForAnnotation = ( cell, annotation) => {
          let cellAttr = 'data-code-cell="' + cell + '"';
          let lineAttr = 'data-code-annotation="' +  annotation + '"';
          const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
          return selector;
        }
        const selectCodeLines = (annoteEl) => {
          const doc = window.document;
          const targetCell = annoteEl.getAttribute("data-target-cell");
          const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
          const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
          const lines = annoteSpan.getAttribute("data-code-lines").split(",");
          const lineIds = lines.map((line) => {
            return targetCell + "-" + line;
          })
          let top = null;
          let height = null;
          let parent = null;
          if (lineIds.length > 0) {
              //compute the position of the single el (top and bottom and make a div)
              const el = window.document.getElementById(lineIds[0]);
              top = el.offsetTop;
              height = el.offsetHeight;
              parent = el.parentElement.parentElement;
            if (lineIds.length > 1) {
              const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
              const bottom = lastEl.offsetTop + lastEl.offsetHeight;
              height = bottom - top;
            }
            if (top !== null && height !== null && parent !== null) {
              // cook up a div (if necessary) and position it 
              let div = window.document.getElementById("code-annotation-line-highlight");
              if (div === null) {
                div = window.document.createElement("div");
                div.setAttribute("id", "code-annotation-line-highlight");
                div.style.position = 'absolute';
                parent.appendChild(div);
              }
              div.style.top = top - 2 + "px";
              div.style.height = height + 4 + "px";
              div.style.left = 0;
              let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
              if (gutterDiv === null) {
                gutterDiv = window.document.createElement("div");
                gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
                gutterDiv.style.position = 'absolute';
                const codeCell = window.document.getElementById(targetCell);
                const gutter = codeCell.querySelector('.code-annotation-gutter');
                gutter.appendChild(gutterDiv);
              }
              gutterDiv.style.top = top - 2 + "px";
              gutterDiv.style.height = height + 4 + "px";
            }
            selectedAnnoteEl = annoteEl;
          }
        };
        const unselectCodeLines = () => {
          const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
          elementsIds.forEach((elId) => {
            const div = window.document.getElementById(elId);
            if (div) {
              div.remove();
            }
          });
          selectedAnnoteEl = undefined;
        };
          // Handle positioning of the toggle
      window.addEventListener(
        "resize",
        throttle(() => {
          elRect = undefined;
          if (selectedAnnoteEl) {
            selectCodeLines(selectedAnnoteEl);
          }
        }, 10)
      );
      function throttle(fn, ms) {
      let throttle = false;
      let timer;
        return (...args) => {
          if(!throttle) { // first call gets through
              fn.apply(this, args);
              throttle = true;
          } else { // all the others get throttled
              if(timer) clearTimeout(timer); // cancel #2
              timer = setTimeout(() => {
                fn.apply(this, args);
                timer = throttle = false;
              }, ms);
          }
        };
      }
        // Attach click handler to the DT
        const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
        for (const annoteDlNode of annoteDls) {
          annoteDlNode.addEventListener('click', (event) => {
            const clickedEl = event.target;
            if (clickedEl !== selectedAnnoteEl) {
              unselectCodeLines();
              const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
              if (activeEl) {
                activeEl.classList.remove('code-annotation-active');
              }
              selectCodeLines(clickedEl);
              clickedEl.classList.add('code-annotation-active');
            } else {
              // Unselect the line
              unselectCodeLines();
              clickedEl.classList.remove('code-annotation-active');
            }
          });
        }
    const findCites = (el) => {
      const parentEl = el.parentElement;
      if (parentEl) {
        const cites = parentEl.dataset.cites;
        if (cites) {
          return {
            el,
            cites: cites.split(' ')
          };
        } else {
          return findCites(el.parentElement)
        }
      } else {
        return undefined;
      }
    };
    var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
    for (var i=0; i<bibliorefs.length; i++) {
      const ref = bibliorefs[i];
      const citeInfo = findCites(ref);
      if (citeInfo) {
        tippyHover(citeInfo.el, function() {
          var popup = window.document.createElement('div');
          citeInfo.cites.forEach(function(cite) {
            var citeDiv = window.document.createElement('div');
            citeDiv.classList.add('hanging-indent');
            citeDiv.classList.add('csl-entry');
            var biblioDiv = window.document.getElementById('ref-' + cite);
            if (biblioDiv) {
              citeDiv.innerHTML = biblioDiv.innerHTML;
            }
            popup.appendChild(citeDiv);
          });
          return popup.innerHTML;
        });
      }
    }
  });
  </script>
</div> <!-- /content -->




</body></html>